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     The world-wide transdermal drug delivery market is quite large, but only a 
small number of agents have FDA approval. The primary reason for such limited 
development of this market is the difficulty in permeating the stratum corneum layer 
of human skin.  Compressed lipid bilayers comprise the continuum portion of this 
layer, which is the primary barrier in skin. Various physical and chemical methods 
have been tested to increase the permeability of the stratum corneum to drugs.  
However, few have succeeded in delivering relevant agents at the appropriate flux 
levels without causing notable skin irritation or damage.  
     In our study, we developed a novel percutaneous delivery enhancing approach. 
Magainin peptide was previously shown to disrupt vesicles which are made from lipid 
bilayer components representative of those found in human stratum corneum and this 
ability of magainin allows us to propose that magainin can increase skin permeability. 
Therefore, we tested the hypothesis that magainin, a peptide believed to form pores in 
bacterial cell membranes, can increase skin permeability by disrupting stratum 
corneum lipid structure. We further hypothesized that magainin’s enhancement 
requires co-administration of a surfactant chemical enhancer to increase magainin 
penetration into the skin. In support of these hypotheses, synergistic enhancement of 
 xxiv 
transdermal permeation can be observed with magainin peptide in combination of N-
lauroyl sarcosine (NLS) in 50% ethanol-PBS solution. The exposure to a known 
surfactant chemical enhancer, NLS, in 50% ethanol solution increased in vitro skin 
permeability to fluorescein 15 fold and the combination of magainin and NLS-ethanol 
synergistically increased skin permeability 47 fold. In contrast, skin permeability was 
unaffected by exposure to magainin without co-enhancement by NLS-ethanol.  
      The exact mechanism of this synergistic effect has not been elucidated, so 
several characterization methods such as differential scanning calorimetry, Fourier 
transform infrared spectroscopy, and X-ray diffraction were applied to investigate the 
mechanism of synergistic enhancement. These analyses showed that NLS-ethanol 
disrupted stratum corneum lipid structure and that the combination of magainin and 
NLS-ethanol disrupted stratum corneum lipids even further. Furthermore, confocal 
microscopy showed that magainin in the presence of NLS-ethanol penetrated deeply 
and extensively into stratum corneum, whereas magainin alone penetrated poorly into 
the skin. Together, these data suggest that NLS-ethanol increased magainin 
penetration into stratum corneum, which further increased stratum corneum lipid 
disruption and skin permeability. 
     In addition, we investigated the enhancement of modified magainin derivitives. 
The modification of magainin did not improve the transdermal enhancement 
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characterisitics of the peptide. The structure and lipid fluidization of peptides were not 
the main factors for percutaneous enhancement.    
     Finally, skin permeability was enhanced by changing the charge of magainin 
peptide via pH change and was dependent on the magainin concentration. We 
modulated pH from 5 to 11 to change the magainin charge from positive to neutral, 
which decreased skin permeability to a negatively charged model drug (fluorescein) 
and increased skin permeability to a positively charged drug (granisetron). This 
suggests that an attractive interaction between the drug and magainin peptide 
improves transdermal flux. Addition of salt above 1 M concentration caused the 
reduction of transdermal permeation, which indicated that permeation is reduced 
when magainin-fluorescein interactions are reduced at high ionic strength. Further 
modulation of pH to 12 increased skin permeability still further, which appeared to 
involve changes in intrinsic skin properties. Maximum skin permeability enhancement 
achieved in this study was 71 fold, which suggests these enhancers can be applied to 
transdermal drug delivery.  
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CHAPTER 1: INTRODUCTION 
 
Over more than two decades, transdermal drug delivery has been developed to 
the stage where transdermal systems represent a feasible way of delivering clinically 
effective drugs. In the USA, out of 129 drug delivery candidate products under 
clinical evaluation, 51 are transdermal or dermal systems  [1]. The worldwide 
transdermal market is currently more than US $ 4 billion and the annual US market 
for transdermal patches is more than US $ 3 billion. This technique represents the 
most successful non-oral systemic drug delivery system. Approximately 13 years ago, 
nicotine patches revolutionized smoking prevention. In addition, Nitroglycerin for 
angina, clondine for hypertension, scopolamine for motion sickness, and estradiol for 
estrogen deficiency are representative examples of successful transdermal patch 
products  [2].  
However, the major challenge in transdermal drug delivery system is to 
increase the variety of drugs which can be administered. This market is dispersed 
amongst only eighteen FDA-approved active agents: scopolamine, nitroglycerin, 
clonidine, estradiol-norethindrone, fentanyl, nicotine, testosterone, ethinyl estradiol-
norelgestromin, oxybutynin, 17-β estradiol, lidocaine, lidocaine-epinephrine, 
estradiol-levonorgestrel, lidocaine-tetracaine, fentanyl HCl, methylphenidate, 
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selegiline, rotigotine, and rivastigmine. Only a small number of drugs are available 
using transdermal patch systems because of the low permeability of human skin 
(especially the outermost stratum corneum layer) which limits daily drug dosage to 
about 10 mg via an acceptable sized patch. Moreover, transdermal drug delivery is not 
suited to all drugs, nor is it justified for all therapies. Most of drugs transdermally 
administered should be small in molecular mass, highly lipophilic and require small 
dosages [1,3,4]. Only a limited number of drugs have been successfully delivered into 
the skin, so various methods such as iontophoresis, electroporation, sonophoresis, 
stratum corneum ablation, microneedles, and chemical enhancers have been 
investigated  [5]. 
Conventionally, active agents are mostly administered to the body by periodic 
applications. In medical treatment, drugs are introduced in intervals by ingestion of 
pills, liquids or by injection and then circulate throughout the body. The concentration 
of the active agent rises and falls, therefore the initially high concentrations may be 
toxic and cause side effects both to the target organ and neighboring structures. When 
the concentration diminishes, which is hard to monitor, careful calculation of the 
amount of the residual active agent should be made to avoid overdosing. Due to 
natural metabolic processes, a second dose must be administered to prevent the 
concentration from dropping below the minimum effective level [6]. 
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In transdermal administration of medication, the above problems can be largely 
eliminated because the drug diffuses over a prolonged period of time directly into the 
bloodstream. The advantages of transdermal delivery include therapeutic benefits like 
sustained plasma concentration profile, reduction of systemic side effects, 
improvement of patient compliance by reducing dosing schedule, avoidance of the 
first-pass metabolism, convenience, patient-friendliness, and non-invasive 
administration [7].  
     In spite of the abundant advantages of transdermal delivery systems, there are 
some obstacles to its widespread application. Transdermal transport of molecules is 
slow due to low permeability of the stratum corneum, the uppermost layer of the skin. 
Another serious obstacle to transdermal drug delivery is the possibility of adverse skin 
reactions known as contact allergic dermatitis [6].  
     In this study we tested the hypothesis that magainin, a peptide believed to form 
pores in bacterial cell membranes, can increase skin permeability by disrupting the 
stratum corneum lipid structure. We further hypothesized that magainin’s 
enhancement requires co-administration with a surfactant chemical enhancer to 
increase magainin penetration into the skin. Additionally, we tested the hypothesis 
that greater increases in skin permeability can be realized by manipulating the charge 
properties of the magainin peptide by changing pH.  
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  We believe this is the first study to demonstrate the use of a pore-forming 
peptide to increase skin permeability. This study also introduces the novel concept of 
using a first chemical enhancer to increase penetration of a second chemical enhancer 
into the skin to synergistically increase skin permeability to a model drug. We hope 
we will be able to propose the mechanism that the pore-forming peptide uses to 















CHAPTER 2: BACKGROUND 
 
2.1. Structure and anatomy of the human skin 
     Skin is one of the largest organs of the body. It consists of two parts: the 
cellular outermost layer, epidermis, and the inner connective tissue layer, dermis. 
Lying between these two layers is a microscopic structure, the basal lamina or 




Figure 2. 1 Schematic representation of the skin. Reproduced from reference [8] 
 
     The epidermis is composed of two parts: the living cells of the Malpighian layer 
and the dead cells of the stratum corneum commonly referred to as the horny layer. 
The prime function of the viable cells of the epidermis is to move progressively 
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through a process of differentiation, eventually expiring to generate the barrier layer 
of stratum corneum [9]. The epidermis is a continually self-renewing, stratified 
squamous epithelium covering the entire outer surface of the body. (Figure 2.2) Over 
most of the body the epidermis ranges in thickness from 0.06 to 0.1 mm. The major 
cell of the epidermis is the keratinocyte and other important cellular elements include 
the melanocyte (the source of melanin pigment), the Langerhans cell which is part of 
the immune surveillance system, and the Merkel cell which functions as a 





Figure 2. 2 Diagram of the different layers of epidermis. Reproduced from 
reference [8] 
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      The stratum corneum is the end product of epidermal differentiation and 
consists of 15 to 25 cell layers over most of the body surface [11]. Change in the 
composition of the lipids during keratinization is shown in Table 2.1. The corneocyte 
is the largest cell in the stratum corneum, approximately 0.5 µm in thickness and 30 
to 40 µm in width. It contains no organelles but is filled with protein, 80% of which is 
high molecular-weight keratin. The intercellular space is filled with lipids organized 
into multiple bilayers and these lipids are of unusual composition. Approximately 
14 % of the stratum corneum, by weight, is lipids. In addition, stratum corneum has 
very low water content [12]. Formation of the stratum corneum is also accompanied 
by the deposition of a 15 nm thick band of protein on the inner surface of the plasma 
membrane, the cornified cell envelope, a structure unique to keratinocytes and a 
hallmark of the terminal differentiation [13].  
The natural function of the skin is to protect the body against exogenous 
material, dehydration, and environmental stress. The major barrier towards inward 
and outward diffusion of compounds is the outermost layer of the skin, stratum 
corneum [14]. Stratum corneum consists of lipid-depleted and keratinized cells 
(corneocytes) embedded in a lamellar lipid-rich interstitium. Unique lipid 





Table 2. 1 Change in the composition of the lipids during keratinization. 
Reproduced from referenc  [15] 
 
Percent ± SEM Epidermis Stratum corneum 
Phospholipids 45 ± 3.6 2.0 ± 0.5 
Cholesterol sulfate 3 ± 0.5 1.5 ± 0.4 
Neutral lipids 44 ± 1.8 66.0 ± 2.8 
Cholesterol 14 ± 1.8 32 ± 2.5 
Free fatty acid 9 ± 1.5 20 ± 2.0 
Triglycerides 12 ± 2.0 2 ± 0.5 
Cholesterol esters 6 ± 1.0 10 ± 1.0 
Squalene 3 ± 0.5 2 ± 0.5 
Sphingolipids 8 ± 1.5 30 ± 3.5 
Glucosylceramides 5.5 ± 0.5 traces 
Ceramides 2.5 ± 0.5 30 ± 3.0 




establishing the barrier function and in maintaining cohesion between 
corneocytes [15].  
The main lipid components of stratum corneum are ceramides, cholesterol, and 
free fatty acids, which make up approximately 50, 25, 10 percent of stratum corneum 
lipid mass [16]. The minor lipid components are glucosylceramides, cholesterol 
sulfate and cholesterol esters. In contrast with cellular membranes, ceramides located 
in the intercellular spaces cannot form bilayers by themselves, so cholesterol, free 
fatty acids, and cholesterol sulfate are required to form ordered structures. The lipid 
bilayer containing these components dramatically reduces skin permeability [17].  
 
1) Ceramides 
     The ceramides in the stratum corneum can be separated into eight classes of 
different polarity, head-group architecture, and fatty acid chain length. The 
differences in chemical structure of the ceramides are assumed to be important for the 
characterisitic organization of stratum corneum lipids [17]. (Figure 2.3) 
 
2) Cholesterol  
     Cholesterol decreases the interfacial line tension between phases, acting at the 
borders between different regions on the surface [18]. Cholesterol is the most 
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abundant individual lipid class in the stratum corneum, accounting for around 25% of 





Figure 2. 3 Structures of the (A) eight major free ceramides and (B) two protein-
bound ceramides of the human stratum corneum. A = α-hydroxy acid; E = ω-
acyl-oxyacid or esterified ω-hydroxy acid; H = 6-hydroxysphingosine; N = 
nonhydroxyacid; O = ω-hydroxy acid; P = phytosphingosine; S = sphingosine. 
Reproduced from reference [20] 
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     Cholesterol is capable of either fluidizing membrane domains or of making 
them more rigid depending on its concentration. The main role of cholesterol in the 
epidermal barrier is to provide a required degree of fluidity to what could otherwise 
be a rigid, possibly brittle membrane system [14].  
 
3) Free fatty acids 
     Free fatty acids increase the lipid lattice density, which is critical for making an 
effective skin barrier [14]. The fatty acids are required for formation of a lamellar 
phase, since this is the principal ionizable lipid class in the stratum corneum [21]. 
Linoleic acid plays a direct role in the epidermial barrier function by incorporating 
two unique sphingolipids: acylglucosylceramide and acylceramide [15]. The fatty acid 
composition of the intercellular lipid plays an important role in the stratum corneum 
barrier and in the pH variations in the different stratum corneum layers [22].  
 
4) Glucosylceramides  
     Glucosylceramides are the precursors of ceramides. Ceramide compounds are 
derived from the deglucosylation of polar glucosylceramides [23].  
 
5) Cholesterol sulfate  
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     Cholesterol sulfate is important for the desquamation process of skin. To inhibit 
certain enzyme activity in the lower layers in stratum corneum and maintain the 
elasticity of the skin, moderate levels of cholesterol sulfate in the intercellular regions 
are necessary. Also, in the presence of cholesterol sulfate, the solubility of cholesterol 
in the lipid mixtures increases [14,24].  
 
2.2. Stratum corneum model 
 
2.2.1 Brick and Mortar Model  [25,26] 
Elias depicted the stratum corneum skin barrier as a brick and mortar structure. 
The corneocytes represent the hydrophilic bricks and the intercellular lipids represent 






Figure 2. 4 Schematic illustration of the brick and mortar model of the SC. 
Reproduced from reference [27] 
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 The corneocytes (C) are represented by the brick-like structures in the 
continuous phase of the lipid bilayer lamellae (LB) that comprise the intercellular 
space. In the stratum corneum - the first 10-20 µm of the skin - corneocytes have 
estimated dimensions of 40 µm in diameter and 0.8 µm in thickness, whereas the 
intercellular space thickness is estimated to be 75 nm [27]. (Figure 2.4) 
 
2.2.2 Domain Mosaic Model  [28,29] 
Since the simplified “Brick and Mortar Model” cannot explain the complexity 
of the physical constraints on the lipid barrier, the “Domain Mosaic Model” was 
proposed. In the crystalline state, lipid aggregates corresponding to such mosaic 
domains are connected to each other by ‘grain borders’ within which the lipid units 
are actually in the fluid crystalline state.  
 
             
 
Figure 2. 5 Domain mosaic model. Note the presence of phase separation between 
liquid crystalline and gel domains. Reproduced from reference [30] 
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     The bulk part of the barrier is mainly in the crystalline/gel state, which prevents 
water loss, and the fluid state grain borders allow some water to permeate the barrier 
towards the corneocytes for keratin pliability. This model provides the necessary 
mechanical properties permitting bending and stress imposed on the skin surface. 
 
2.2.3 Sandwich Model  [14,31] 
The “Sandwich Model” was proposed in order to compensate for some flaws 
found in “Domain Mosaic Model”. The “Domain Mosaic Model” requires the 
creation of new interfaces throughout the stratum corneum. Because liquid phase 
forms a narrow continuous pathway from the superficial stratum corneum layers 
down to the viable epidermis, substances would be able to diffuse only through this 
tortuous liquid phase, which might reduce the diffusional resistance of the skin. The 
“Sandwich Model” is based in the molecular arrangement of the lipids in the 13 nm 
phase. The liquid sublattice is located in the central part of the repeating unit and 
unsaturated linoleic acid, ceramide, and cholesterol are present in this central region. 
The liquid sublattice changes into a less mobile sublattice composed of hydrocarbon 
chains, which results in a densely packed lipid layer. Substances passing the stratum 
corneum lipid regions need to pass the crystalline lipid lamellae perpendicularly to the 
basal plane and permeate through two densely packed layers and one less densely 
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Figure 2. 6 Model for molecular arrangement of the long periodicity phase (LPP). 
The broad-narrow-broad pattern found in RuO4 fixed stratum corneum is shown 
in right panel. A molecular model is presented in the middle panel, in which 
CER1 plays an important role in dictating the broad–narrow–broad sequence. 
Furthermore, the fluid phase is located in the central narrow band. In adjacent 
regions the crystallinity is gradually increasing from the central layer. Even in 
the presence of the central fluid layer the barrier function is retained while 
deformation as a consequence of shear stresses is facilitated. The latter might be 
of importance for the elastic properties of the skin. Reproduced from 
reference [31] 
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2.3. Transdermal drug delivery 
 
     Transdermal drug delivery systems (TDDS) deliver therapeutic quantities of 
drug through the skin and into the systemic circulation for their general effects. In 
such systems, the drug should penetrate across the skin to the underneath blood 
supply without drug accumulation in the dermal area. The drug initially penetrates 
through stratum corneum – the main rate limiting skin barrier – and then passes 
through the deeper epidermis and dermis. When drug reaches the dermal area, it 
becomes available for systemic circulation [32].  
  Some advantages of transdermal drug delivery are as follows [3,6,33].  
• It can provide constant blood levels in the plasma for drugs with a narrow 
therapeutic window, thus minimizing the risk of toxic side effect or lack of 
efficacy.          
• It can avoid first-pass metabolism in the gastrointestinal tract and liver, which 
allows drugs with poor oral bioavailability and short biological half-lives to be 
administered at most once a day, which can result in improved patient compliance. 
• It can also avoid the problems of the gastrointestinal environment, such as 
chemical degradation of the drug and the resulting gastric irritation.  
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• It can provide a noninvasive alternative to parenteral, subcutaneous and 
intramuscular injections. The application of a patch-like device to the skin surface 
is a procedure that allows continuous intervention. 
• It can provide predictable and extended duration of activity to reduce the 
frequency of dosage and minimize inter- and intrapatient variation. 
• The large and readily accessible surface area (1-2 m2) of skin allows many 
placement options for transdermal absorption. 
• It is suitable for patients who are unconscious or vomiting and rely on self-
administration  
     The transdermal drug delivery systems have disadvantages also. Only potent 
drugs are suitable candidates owing to the low permeability of skin and the potential 
of some drugs to cause skin irritation. The factors influencing the suitability of drugs 
for transdermal delivery using current technology are as follows [6,33].  
• The daily systemic dosage must be below 20 mg. 
• The molecular size of drug must be below 500 Da. 
• The log P (lipophilicity) of drug should be in the range 1-3 
• The melting point of drug should be below 200 oC. 
• The drug should not irritate the skin 
• The drug should not bring about immune response in the skin.  
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     Table 2.2 describes some drugs currently using transdermal delivery. Although 
only a small numbers of drugs are currently used in transdermal systems, some other 
drugs being investigated recently include: diltiazem, isosorbide dinitrate, propranolol, 
nifedipine, mepindolo, verapamil, levonorgestrel/esradiol, physostigmine, xanomeline, 
naltrexone, methadone, buspirone, bupropion, and papaverine [32].  
 
2.4. Percutaneous penetration enhancement 
 
     Penetration enhancers are substances that enhance the absorption of molecules 
through the skin by temporarily increasing its permeability. Ideal penetration 
enhancers should be pharmacologically and chemically inert, chemically stable, 
nontoxic, nonirritating, nonsenstizing, nonphototoxic, noncomedogenic, compatible 
with the drug and excipients, nonallergenic, ordorless, tasteless, colorless, 
cosmetically acceptable, and inexpensive. Further, they should have good solvent 
properties, a high degree of potency with specific activity, and produce reversible 
effects on skin properties. In addition, they should not lead to the loss of body fluids, 






Table 2. 2 Characteristics of several transdermally drugs delivered. 
Reproduced from reference  [2] 
 
Active Ingredient MW Daily Dose Type 
Clonidine 230 0.1-0.3 mg Reservoir 
Estradiol 272 0.025-0.1 mg Drug–in-Adhesive 
Ethinyl Estradiol 
w/ Norelgestromin 
296/328 0.15/0.02 mg Drug–in-Adhesive 
Fentanyl 337 Various Reservoir / Martix 
Lidocaine 234 Not stated Drug–in-Adhesive 
Nicotine 162 7-21 mg 
OTC product 
Reservoir / Martix 
Nitroglucerine 227 1.4-11.2mg Drug–in-Adhesive /Reservoir 
Scopolamine 303 0.33 mg Reservoir 





2.4.1 Chemical percutaneous penetration enhancement 
     Chemical enhancers are assumed to operate in the intercellular spaces of the 
stratum corneum, which is the major diffusion route for lipophilic moieties. Although 
exact mechanisms have not been clearly elucidated, it is believed that they will have 
multiple effects once absorbed into the stratum corneum. Many different classes of 
chemical penetration enhancers have been investigated, including surfactants, fatty 
acids, esters, Azone, amines, amides, amino acetates, sulfoxides, urea, unsaturated 
cyclic ureas, terpenes, liposomes, and alcohols [34].  
     Azone (Figure 2.7) is a material that was developed specifically as a skin 
penetration enhancer to improve the absorption of topical agents [35]. Azone 
provokes dynamic structural disorder of the intercellular lamellar lipid structure 
throughout the stratum corneum and the creation of fluid domains involving the 
intercellular lipids, which was suggested by 2H NMR assay [36]. Another mechanism 
was also proposed based on the alteration of the lateral bonding within stratum 
corneum lipid lamellae [37].  
    
 
Figure 2. 7 Strucutre of Azone. Reproduced from reference [37] 
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     Fatty acids have potential utility as skin permeation enhancers to improve the 
transdermal or topical delivery of drugs. In particular, oleic acid has been studied 
extensively [38]. The suggested mechanism of oleic acid–induced skin permeation 
includes lipid disordering, lipid fluidization, and phase separation deduced from in 
vivo  [39] and in vitro  [40] analysis. 
     Terpenes are hydroxyl cotaining dienes that are constituents of essential 
oils [41]. They are considered nontoxic with low irritancy and designated as 
Generally Recognized As Safe (GRAS) by the FDA [42]. The respective alcoholic 
terpenes, carvacrol, linalool and terpineol, were investigated in different solvents as 
transdermal enhancers: ethanol  [43] and propylene glycol  [44]. Those terpenes 
show high permeation of haloperidol in both solvents. 
     Ethanol was the good choice for the first enhancer to be incorporated into 
transdermal drug delivery. The interactions of ethanol with skin in terms of its 
permeation, primary irritation and cutaneous metabolism are better characterized than 
any other enhancer [45]. A permeation study of ethanol concentration demonstrated 
different result. Kurihara-Bergstrom showed 63 % is optimum  [46], but Sznitowska 
found 25-50 % is the optimum concentration for skin permeability enhancement [47]. 
The mechanism of ethanol permeation enhancement was suggested as alteration of the 
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stratum corneum keratinized protein conformation, the extended hydrophilic domain 
between lipid polar head group, or lipid extraction [46].  
     Recently, a silicon-based transdermal penetration enhancer which was expected 
to show a low irritation to the skin was developed. This enhancer was considered to 
prevent inflammation even after penetration through the skin, because it would remain 
in the stratum corneum region owing to its high lipophilicity [48]. 
     Surfactants as a chemical enhancer are discussed below. 
 
2.4.2 Skin penetration enhancement by surfactant. 
     Many surfactants are capable of interacting with the stratum corneum to 
increase the absorption of drugs and other active compounds from products applied to 
the skin. Skin penetration measurements are valuable in quantifying these effects and 
observing the influence of surfactant chemistry and concentration.  
     A surfactant interacts with skin by depositing onto the stratum corneum, 
thereby disorganizing its structure. Then surfactant can solubilize or remove lipids or 
water-soluble constituents in or on the surface of the stratum corneum. Finally it can 
be transported into and through the stratum corneum. This last effect is related to the 
surfactant and stratum corneum protein interaction and epidermal keratin 
denaturation [8].  
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     In general, anionic surfactants are more effective than cationic and nonionic 
surfactants in enhancing skin penetration of target molecules. Some anionic 
surfactants interact strongly with both keratin and lipids, whereas the cationic 
surfactants interact with the keratin fibrils of the cornified cells and result in a 
disrupted cell-lipid matrix. Nonionic surfactants enhance absorption by inducing 
fluidization of the stratum corneum lipids [49].  
     Scheuplein and Ross reported that the capacity of the statum corneum to retain 
significant quantities of membrane-bound water is reduced in the presence of sodium 
dodecanoate and sodium dodecyl sulfate [50]. This effect is readily reversible upon 
removal of the agents. These investigations proposed that anionic surfactants alter the 
permeability of the skin by acting on the helical filaments of the stratum corneum, 
thereby resulting in the uncoiling and extension of α-keratin filaments to produce β-
keratin. Then they cause an expansion of the membrane, which increases 
permeability [50]. However, more recent findings suggest that impairment of the 
skin’s barrier properties is unlikely to result from changes in protein conformation 
alone. Based on differential scanning calorimetry results, sodium lauryl sulfate (SLS) 
disrupted both the lipid and the protein components [51].  
     The amount of surfactant that penetrates the skin after the disruption of the skin 
barrier depends on the monomer activity and the critical micelle concentration (CMC). 
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Above the CMC, the added surfactant exists as micelles in the solution and micelles 
are too large to penetrate the skin.  
     The extent of barrier disruption and penetration enhancement of a surfactant is 
also strongly dependent on surfactant structure, especially alkyl chain length. In 
general, studies have shown that surfactants having 12 carbons in their alkyl chain 
cause more disruption to the skin barrier and allow drugs to penetrate more readily 
than those that have more or less than 12 carbons. The explanation for this optimum 
of 12 carbons is not known yet [8].  
 
2.4.3 Physical percutaneous penetration enhancement 
     Physical methods use electrical or mechanical phenomena to increase skin 
permeability. Iontophoresis, electroporation, sonophoresis, stratum corneum ablation, 
and microneedles are most promising methods. 
     Iontophoresis can transport charged molecules into the skin by electrophoresis 
using the passage of a direct electric current through the electrolyte solution 
containing the charged molecules to be delivered [52].  
     Electroporaton applies a brief high-voltage electric field pulse to create 
transient aqueous pathways across the lipid bilayers of stratum corneum and thus 
enhance permeation across bilayer lipid membranes in the stratum corneum [53].  
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     Sonophoresis is the application of ultrasound to increase the permeation of 
drugs through the skin. The mechanism appears to be disruption of stratum corneum 
lipid bilayer structure [54].  
     Stratum corneum ablation can be achived by micro-dermbrasion which use a 
stream of aluminum oxide crystals  [55] and laser-ablation which use high powered 
thermal pulse to vaporize a stratum corneum [56].  
     Microneedles can pierce the skin and create micrometer-scale pores. Channels 
of micrometer dimensions are much larger than macromolecules and dramatically 
increase skin permeability to large drug molecules [57].  
     In addition, magnetophoresis which use the ability of magnetic fields to deliver 
diamagnetic materials through skin  [58] and photomechanical waves which enhance 
the drug penetration across the skin by irradiating a drug solution with laser pulse and 
stressing the stratum corneum with photomechanical  [59] have also been 
investigated. 
 
2.4.4 Metabolic percutaneous penetration enhancement 
     A limitation of conventional topical enhancement method was the usage of 
devitalized skin, because non-viable skin does not show metabolic response against 
barrier perturbation [60]. In case of in vivo skin, if the lipid - the determinant of skin 
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barrier function - was perturbed by chemical agents, the skin barrier recovery will be 
followed by lipid synthesis [61]. The concept of metabolic percutaneous enhancement 
method came from research that transdermal delivery enhancement by inhibition of 
critical metabolic sequence that restores skin barrier function. The classification of 
various metabolic percutaneous enhancement methods are as followings: lipid 
synthesis inhibitors, lamellar body secretion inhibitors, extracellular acidification 
inhibitors, sphingosine (precursor for ceramide) inhibitor, etc [60,62].  
 
2.5. Antimicrobial and cell-penetrating peptide 
 
     Antimicrobial peptides have been shown to kill microbes with impressive 
potency and specificity and developed as therapeutic agents for infectious disease 
treatment. Permeating peptides can also be applied as carriers for delivery of foreign 
substances into microorganisms [63]. The natural antimicrobial peptides are normally 
12-50 amino acids long and share two main characteristics. First, they are poly-
cationic with positive net charge of more than +2. Second, they have the ability to 
form amphipathic structures with both positively charged and hydrophobic 
regions [63].  
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     Microbial cell permeation by peptides can be seen as a three-step process. The 
first is an electrostatic attraction of the peptide to the membrane surface. (Figure 2.8) 
The second is membrane disruption, penetration and some reorganization of the 
peptide structure. Finally, peptide passes the membrane and gains access to the 
intracellular processes [64]. Within thes general framework, there are a number of 






Figure 2. 8 The membrane target of antimicrobial peptides of multicellular 
organisms and the basis of specificity. Reproduced from reference [65] 
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1) Barrel stave model 
     The “Barrel stave” mechanism describes the formation of transmembrane pores 
by bundles of amphipathic α-helices, in which their hydrophobic surfaces interact 
with the lipid domain of the membrane and the hydrophilic surfaces point inward 
producing an aqueous pore [66]. (Figure 2.9)  
     This model involves four steps to form a transmembrane pore. 1 Monomers 
bind to the membrane in an α-helical structure 2 Molecules recognize the membrane-
bound monomer at low surface density of bound peptide 3 At least two assembled 
monomers insert into the membrane to initiate the formation of a pore  
4 Progressive recruitment of additional monomers increases the pore size 
 
2) Carpet model 
     The carpet model describes a pore formation mechanism where amphipathic α-
helical peptides bind to the surface of a membrane and cover it in a carpet-like 
manner. In contrast to the “Barrel stave model”, peptides are not inserted into the 
hydrophobic core of membrane, but instead bind to the phospholipids head-groups. 
Additionally, peptides do not need to adopt a specific structure for their binding. 
     This model involves four steps to form a transmembrane pore [67]. 1 Peptide 
monomer has a tendency to bind to the phospholipids head group 2 Alignment of the 
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peptide in the surface of membrane, their hydrophilic surface faces the phospholipids 
head group 3 Peptide rotation reorients them toward the hydrophobic core of 
membrane 4 Disintegration of membrane by disrupting the bilayer curvature  






Figure 2. 9 Barrel-stave (to the right) and the carpet-like (to the left) models 




3) Shai-Matsuzaki-Huang model  
     This model explains the activity of most antimicrobial peptides and proposes 
the interaction of the peptide with the membrane, displacement of lipids, alteration of 
membrane structure, and entry of the peptide into the inside of cell in a some 
cases [65].  
 Carpeting of the outer leaflet with peptides  Integration of the peptide into the 
membrane and thinning of the outer leaflet. The surface area of the outer leaflet 
expands relative to the inner leaflet, resulting in strain within the bilayer (jagged 
arrows).  Phase transition and `wormhole' formation. Transient pores are formed at 
this stage.  Transport of lipids and peptides into the inner leaflet.  Diffusion of 
peptides onto intracellular targets (in some cases).  Collapse of the membrane into 






Figure 2. 10 The Shai-Matsuzaki-Huang model of the mechanism of action of an 
antimicrobial peptide. An α-helical peptide is depicted. Lipids with yellow head 
groups are acidic, or negatively charged. Lipids with black head groups have no 
net charge. Reproduced from reference [65] 
 
 
     A number of antimicrobial peptides have been discovered. These include 
Defensins from mammalian neutrophilies, Cecropins from insects, Melittin from bee 
venom, Tachyplesins from horseshoe crab hemolymph and Magainin from frogs [65].  
     Magainin 2 is a 23-residue helical peptide isolated from the skin granular gland 
of the African clawed frog named Xenopus laevis that exhibits a broad spectrum of 
antimicrobial activity as well as tumoricidal properties [68]. It has a net +4 charge at 
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physiological pH and binds to negatively charged phospholipid membranes with the 
aid of electrostatic interactions, forming an amphiphilic helix and permeabilizing the 




Figure 2. 11 Schiffer–Edmundson wheel projection of the N-terminal 22 amino 
acids of magainin-2. Number 1 represents residue 1 of the peptides. Blue 
indicates hydrophobic amino acids and red indicates hydrophilic amino acids. 
Reproduced from reference [66] 
 
 
     By now it is well established that magainin acts by disrupting cell membranes 
rather than by interacting with specific protein targets, subsequently causing an 
increase in membrane permeability and leading to cell lysis. The mechanism of 
magainin-lipid interactions have been proposed by Matsuzaki [69]. (Figure 2.12) 
Magainins take on an amorphous structures in aqueous solution and form an 
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amphiphilic helix on membrane binding. Electrostatic interaction between magainin 
and lipid membranes plays a critical part. The helix lies parallel to the membrane 
surface due to a balanced hydrophobic and hydrophilic angle. Five helices form a 
membrane-spanning pore consisting of a dynamic, peptide-lipid supra-molecular 
complex. Upon  the disintegration of the pore, a fraction of the peptides translocate 




Figure 2. 12 A model for magainin 2-lipid bilayer interactions (A) Membrane 
binding accompanying helix formation. The shaded area represents the 
hydrophobic surface of the amphiphilic helix. (B) Formation of the pore 
composed of a dynamic, peptide-lipid supra-molecular complex. (C) 
Translocation of the peptide into the inner leaflet upon the disintegration of the 
pore. Reproduced from reference [70] 
 
 
     Magainin is considered as a good candidate for therapeutic agents because it is 
selectively active toward bacterial membranes. This selectivity originates from the 
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following factors. 1 The outer membranes of eukaryotic cells are composed of 
zwitterionic lipids 2 Eukaryotic cell membranes are rich in cholesterol which inhibit 
magainin – induced lysis 3 Bacterial cells have inside-negative transmembrane 
potentials causing magainin – induced lysis [71].  
     However, in most cases the detailed molecular mechanism of the antibiotic 
action is still unknown [72].  
 
2.6. Peptide enhancement 
 
     Transdermal delivery of drug using peptides as enhancers has not been studied 
well and most of research was based on the conjugation of peptides with target 
molecules that we want to deliver. Protein transduction domains - a class of small 
peptides penetrating the plasma membrane of mammalian cells - were used as carriers 
to deliver peptide into the skin in therapeutic levels [73]. The conjugate of 
heptarginine oligomers to cyclosporine A was successfully delivered topically and 
even entered target tissue T-cells, which resulted in functional inhibition of cutaneous 
inflammation [74]. Antennapedia transduction sequence (ANTP) linked to an 
antigenic peptide was used as a peptide-based vaccine transdermally penetrated into 
the cells of the epidermis and dermis. Then, it derived a cytotoxic T-lymphocyte 
 35 
(CTL) response [75]. TD-1 peptide was developed by the phage display technique and 
it delivered insulin into the skin. The mechanism behind this phenomenon has not 
been elucidated yet, but it is thought that TD-1 might create a transient pathway in the 
skin which enabled insulin to penetrate through the skin possibly via hair follicles and 
get to the systemic circulation [76].  
  
2.7. Synergistic Enhancement 
 
     Whereas the aforementioned enhancement methods have shown enhancement 
of transdermal drug penetration, their combinations have been hypothesized to be 
more effective compared with each of them alone. In addition to transdermal drug 
penetration enhancement, a combination of enhancement methods should reduce the 
severity of the enhancers required to achieve the desirable flux of drug. However the 
effect of the enhancers that can be applied on the skin is limited by safety issues and 
irritation of skin. If we combine two or more enhancers, one can reduce the required 
concentration of individual enhancers. As a result, a combination of enhancers can 
increase the safety of enhancers and may increase the total enhancement [77].  
     Most synergistic enhancement applications have been carried out using a 
combination of a physical - especially electro-physical methods - and a chemical 
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enhancer. Iontophoresis showed great synergistic enhancement with chemical 
enhancers such as Azone  [78], N-decylmethyl sulfoxide  [79], oleic acid  [80], 
lauric acid  [81], linoleic acid -menthone in combination  [82], and surfactant  [83]. 
Electroporation with anionic lipid  [84], heparin  [85], sodium thiosulafe-urea  [86], 
and surfactant  [87] also showed synergistic enhancement. Finally, even ultrasound 
synergistically enhanced skin permeability with various chemical enhancers [88,89].  
     Synergistic effects between chemical enhancers have also been reported. 
Karande and coworkers investigated a huge number of binary mixtures of chemical 
enhancers using a high-throughput screening method studied and the mechanism of 
synergistic enhancement of a certain chemical enhancer mixture by FT-IR and 
NMR.  [90,91] Combinations of chemcial enhancers and more polar co-solvents have 
also been reported, suggesting that the latter facilitate the solubilization of the former 
within the stratum corneum, thus amplifying the lipid-modulating effect [77]. The 
synergistic effects of occlusion, chemical enhancer and solvent on skin permeability 






2.8. Experimental Tools 
 
2.8.1 Multi-photon excitation microscope analysis      
In this study, to investigate the structure of human skin and the distribution of 
our model target drug (fluorescein) and magainin peptide (fluorescent-tagged 
magainin peptide) in the stratum corneum, multi-photon microscopy has been used.  
     While histological analysis has been widely used to study tissue morphology, 
some tissue information is not preserved due to the fixation and embedding process. 
In order to get 3-D information without loss of the sample, confocal microscoy was 
introduced. However, reflected confocal microscopy has limitations such as inability 
to get tissue biochemical information and image contrast which is generated by index 
of refraction mismatch. Therefore, multi-photon microscopy was developed, and this 
new tool has the following advantages over the original confocal method: more 
suitable for investigating thick tissue, higher light-detection efficiency, and less 
phototoxicity. A comparison of collection geometry between these two tools is shown 
in Figure 2.13 [93].  
     As mentioned above, multi-photon microscopy is a new tool for noninvasive 




Figure 2. 13 A comparison between the collection geometry of two-photon and 
confocal detection schemes. In the two photon case, no detection pinhole is used, 
and the scattered photons can be better detected with a large area detector. 
Reproduced from reference [93] 
 
used to visualize in vitro permeant spatial distributions across human cadaver skin. In 
addition, it can reduce sample photobleaching and increase three-dimensional depth 
discrimination [94].  
    Two-photon excitation is a good fluorescence technique to assess tissue structure 
down to the depth of several hundred micrometers. Tight focusing in a laser scanning 
microscope enables a dye molecule to simultaneously absorb two long-wavelength 
photons to reach its excited state. The long wave length photon source used in multi-
photon microscopy has light penetrate into the media with a high degree of scattering. 





Figure 2. 14 Schematics of a simultaneous two-photon fluorescence and confocal 
reflected light microscope. Reproduced from reference [93] 
 
 
quantitative analysis of average transport properties in the skin [27]. Figure 2.14 
shows a typical multi-photon microscopy design. 
 
2.8.2 FT-IR ( Fourier Transform InfraRed Spectroscopy ) 
     The technique of Fourier Transform InfraRed (FT-IR) spectroscopy has been 
used extensively to study the phase of lipid membranes. The lipids of the stratum 
corneum can be studied by this technique. Unlike other membrane systems where 
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samples are suspended in water, stratum corneum samples are evaluated as intact 
sheets [95].  
     A typical FTIR spectrum of porcine stratum corneum is shown in Figure 2.15. 
The peaks caused by carbon-hydrogen stretching vibrations have been extensively 
investigated and these two prominent peaks occur near 2920 and 2850 cm-1 for the 
asymmetric and symmetric C-H vibrations of the long chain hydrocarbons of lipids. 
Because the height and area of these two bands are proportional to the amount of the 
lipids present, any extraction of lipids from stratum corneum results in a decrease of 
peak height and area [96]. Fluidization of stratum corneum lipids also enhances the 
permeation of drugs. The shift of C-H stretching peaks to higher wave number and 
increase in their peak width indicate fluidization of stratum corneum lipids [97].  
     Conformational change of stratum corneum protein can be explained by FT-IR 
spectroscopy. The bands located between 1800 and 1500 cm-1 correspond to protein 
absorption. Denaturation of protein is correlated with amide I band (1700-1600 cm-1) 
which is sensitive to the protein conformation. This band provides information on 
four different protein structures: α-helices (1660-1650 cm-1), β-sheets (1640-1620  
cm-1), random coils (1650-1640 cm-1), and antiparallel β-sheets and β-turns (1695-




Figure 2. 15 The typical infrared (IR) spectrum of stratum corneum. Reproduced 
from reference  [95] 
 
2.8.3 DSC (Differential Scanning Calorimetry) 
     Differential scanning calorimetry (DSC) is employed to measure directly the 
effects of transdermal permeation enhancers on the thermal phase properties of 
stratum corneum [40].  
     Human stratum corneum is characterized by four transitions in the 20-120 oC 
range. Three major phase transitions occur near 65, 80 and 95 oC. (Figure 2.16) In 
addition, a small peak which is not present in all samples occurs near 35 oC [100]. 
From thermal reversibility, extraction and other assay tools, four peaks can be 
ascribed to structural changes associated with various components as follows: 35 oC – 
 42 
lipid, 65 oC – lipid, 80 oC – lipid & protein, 95 oC – protein. Wide angle X-ray 
experiments with thermal analysis have shown that this first peak is due to a change in 
lipid packing. The fourth peak is assumed to be the intracellular keratin denaturation. 
In case of the third peak, it has been interpreted as protein-lipid associated thermal 
behavior or complete destruction of the lipid bilayer structure. The second peak is 
interpreted as the stacking of the lamellae in the stratum corneum. 
     Interaction of a chemical or peptide enhancer with lipids or protein is shown as 
a change in transition temperature or shape in DSC graph. For example, the decrease 
of both the 2nd and 3rd transition temperatures indicate fluidized states of stratum 




Figure 2. 16 The DSC thermal profile of Human stratum corneum. Reproduced 
from reference [100] 
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2.8.4 X-Ray Diffraction 
     The main diffusion barrier of stratum corenum is the intercellular lipid domains. 
Exploring physical properties and molecular structure of these domains is critical in 
the transdermal delivery study. X-ray diffraction analysis is a very useful tool to 
obtain structural information on lipid domains which are well-structured arrays [101]. 
Two X-ray diffraction methods have been used: small and wide angle X-ray 
diffraction. Small angle X-ray diffraction (SAXD) has been demonstrated to be useful 
to study the structure of the residual tissue after treatments, in particular, the 
intercellular lipids [102]. This method shows structural knowledge with large repeat 
distances on the order of 50-150Å and reveals that the stratum corneum lipids are 
organized in lamellar phases with two periodicities of approximately 6 nm (short 
periodicity phase) and 13 nm (long periodicity phase)  [103]. Wide angle X-ray 
diffraction (WAXD) has been shown to be useful in determining the components of 
the disaggregated fraction and the type of links existing between them. This method 
provides structural information using a small repeat distance on the order of 3-10Å. 
White et al. found that intact stratum corneum from the hairless mouse gave sharp 
wide angle X-ray reflections at 0.38 nm and 0.46 nm [103].  
     The use of this strategy provides new knowledge of the structural stratum 
corneum modifications associated to disaggregation, possibly related to the 
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desquamation process [13]. In the damaged stratum corneum prepared by treatment 
with sodium dodecyl sulfate, small-angle diffraction peaks disappear and only the 
wide maxima remain around 1st, 2nd and 3rd order diffraction peaks. These facts 
indicate that in the normal stratum corneum, the lamellar structure is ordered and in 















CHAPTER 3: SYNERGISTIC ENHANCEMENT OF SKIN 




 While most drugs are administered orally, there are numerous advantages to 
the transdermal route. These advantages include the potential for sustained release, 
controlled input kinetics, improved patient compliance, and avoidance of first-pass 
metabolism in the gastrointestinal tract. However, human skin is a very effective 
barrier and severely limits the transdermal delivery of drugs [4]. Corneocytes 
embedded in a lipid bilayer matrix comprise the unique hierarchical structure of the 
stratum corneum that provides the skins barrier properties. Only a few drug molecules 
of optimal physicochemical properties can penetrate the skin sufficiently to be 
therapeutically efficient. Intercellular lipids in the human stratum corneum principally 
consist of ceramides, fatty acids, cholesterol, and cholesteryl sulfate that are 
assembled into multi-lamellar bilayers [106]. [105]  
 In order to improve transdermal drug delivery, various penetration enhancers 
which disrupt the aforementioned structural hierarchy to decrease the barrier 
resistance of the stratum corneum have been investigated previously. Many 
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compounds have been used as penetration enhancers, including Azone derivatives, 
fatty acids, fatty esters, sulphoxides, alcohols, pyrrolidones, glycols, surfactants, and 
terpenes [106]. Among the various chemical enhancers, surfactants have been widely 
investigated as transdermal permeation enhancers, and also have a long history of use 
as emulsifiers, stabilizers, and suspending agents in many topical pharmaceutical 
formulations [107].  
     Many surfactants can interact with the stratum corneum to increase the 
penetration of drugs applied to skin [108]. Anionic surfactants have been shown to 
disrupt the intercellular lipid lamellae and to cause selective loss of intercellular 
lipids [109]. Among the various anionic surfactants, N-lauroylsarcosine (NLS) has 
been used as a permeation enhancer and has shown a synergistic improvement of 
transdermal flux when used in combination with other enhancers, such as squalene 
and vitamin E [111]. [110]When mixed with sorbitan monolaurate, the formulation 
exhibited not only synergistic transdermal flux enhancement, but also reduction of 
skin irritation [91].  
Synergistic effects between chemical enhancers and various solvents have also 
been reported. A combination of surfactant and 50% propylene glycol showed strong 
synergistic effects on skin permeability [111]. Polar solvents, such as ethanol, have 
been reported not only to have direct effects on skin permeability, but also to facilitate 
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the solubilization of enhancers within the stratum corneum, thus further amplifying 
the lipid-modulating effect [3]. Ethanol is a known enhancer for the transdermal 
delivery of lipophilic drugs and is currently commercialized in transdermal systems 
for estradiol and fentanyl [112].  
Given the observations that formulations combining lipid-disrupting penetration 
enhancers and appropriate solvents can be especially effective to increase skin 
permeability, we sought to study the mechanism by which this enhancement occurs 
using mixtures of NLS and ethanol as a model system. We hypothesize that NLS and 
ethanol synergistically increase skin permeability by increasing the fluidity of stratum 
corneum lipid structure. This hypothesis was tested by measuring the effect of NLS 
and ethanol concentrations on skin permeability to the model fluorescent probe 
fluorecein.  
The mechanism of action was further investigated using skin resistance 
measurements, differential scanning calorimetry (DSC) and Fourier transform 
infrared spectroscopy (FTIR). Measurement of skin resistance can be used as a 
‘generic’ measure of skin permeability that does not depend on the specific 
characteristics of target molecules such as hydrophobicity and charge. DSC and FTIR 
measurements allow us to probe the intercellular lipid domain of the stratum corneum 
to provide information especially on lipid fluidization. 
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3.2. Materials and Methods 
 
3.2.1 Skin preparation 
Human cadaver skin was obtained from the National Disease Research 
Interchange (Philadelphia, PA, USA) or Emory University School of Medicine 
(Atlanta, GA, USA) and stored at -75 oC until use for permeation studies with 
approval from the Georgia Tech Institutional Review Board. Immediately prior to a 
diffusion experiment, whole skin was thawed in deionized water at 30 oC for 1 h. 
Epidermis was isolated from dermis using a heat separation method [113], in which 
the skin was immersed in deionized water for 2 min at 60 oC. The epidermis was then 
carefully peeled away from the dermis with a spatula and used for the diffusion or 
other experiments. 
For experiments on isolated stratum corneum, a stratum corneum sheet was 
isolated from human epidermis by trypsin digestion. The epidermis was incubated in 
phosphate-buffered saline (Sigma Aldrich, St.Louis, MO, USA) containing 0.25% 
trypsin (Mediatech, Herndon, VA, USA) and 0.0l% gentamicin (Clonetics, 
Walkersville, MD, USA) at 32 oC for 24 h. The isolated stratum corneum then was 
rinsed with distilled water three times and stored on polymer-coated paper (Fisher 
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Scientific, Waltham, MA, USA) under vacuum (KNF Neuberger, Trenton, New 
Jersey, USA) overnight at room temperature, 23 - 24 oC [46].  
 
3.2.2 Transdermal flux measurements  
Transdermal flux experiments consisted of three steps. The first step was the 
pretreatment of skin with a chemical enhancer formulation in a vertical Franz 
diffusion glass cell apparatus (PermeGear, Bethlehem, PA, USA). This Franz cell was 
used to hold epidermis samples (0.7 cm2 exposed skin surface area) between the 
donor (upper) and receiver (lower) chambers during an in vitro permeation 
experiment. The stratum corneum side was exposed to 0.3 ml of the enhancer 
formulations in the donor chamber. Solutions of varying NLS (98%, Fluka, Buchs, 
Switzerland) concentrations in solvents of various ethanol (Sigma Aldrich, St.Louis, 
MO, USA) concentrations was placed in the donor chamber, and the Franz cell was 
kept in the refrigerator at 4 oC for 12 h for pretreatment. The concentration of NLS 
solution used in the penetration experiment was 2 % (w/v) and the concentration of 
ethanol was 50 % (v/v) in water, unless otherwise noted. 
The second step was an equilibration step. The Franz cell was placed in a 
heater/stirrer block (PermeGear) maintained at 37 oC and stirred at 455 rpm for 3 h. 
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For the final step, the chemical enhancer formulation was removed from the 
donor chamber and 0.3 ml of 1 mM fluorescein (Sigma Aldrich, St. Louis, MO, USA) 
in PBS buffer solution was placed in the donor chamber. The amount of fluorescein in 
the receiver chamber was measured by calibrated fluorescence spectroscopy (Photon 
Technology International, Birmingham, NJ, USA) every hour for 5 h to determine the 
transdermal fluorescein flux. At each sample time, all of the solution in the receiver 
chamber was removed and replaced with fresh PBS.  
 
3.2.3 Skin resistance measurements 
 The electrical resistance across the epidermis was measured by a Keithley 3322 
LCZ meter (Keithley Instruments, Cleveland, OH, USA). A Ag/AgCl disk electrode 
(In Vivo Metric, Healdsburg, CA, USA) was inserted into the receiver chamber 
through the sampling outlet of a vertical Franz diffusion cell apparatus and another 
Ag/AgCl electrode was placed in the donor chamber.  
  
3.2.4 Differential scanning calorimetry 
DSC was used to characterize the thermal transitions in stratum corneum 
samples that were either untreated or treated with a chemical enhancer formulation. 
Thermal analysis employed a DSCQ100 differential scanning calorimeter fitted with a 
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refrigerated cooling system (TA Instruments, New Castle, DE, USA). Several pieces 
of stratum corneum were each soaked in various chemical enhancer formulations for 
24 h at 4 oC and then washed with PBS solution. The stratum corneum samples were 
desiccated under vacuum for 12 h, and were hermetically sealed within an aluminum 
holder (PerkinEelmer, Wellesley, MA,USA). Samples were heated from 0 oC to 120 
oC at a heating rate is 10 oC /min.   
 
3.2.5 Fourier transform infrared spectroscopy 
Prior to spectral analysis by FTIR, several pieces of stratum corneum were treated 
as described for DSC samples, but were not desiccated. Using a Magma-IR 560 FTIR 
spectrometer (Nicolet, Thermo Electron Corporation, Waltham, MA, USA), all 
spectra (4/cm-1 resolution, representing the average of 64 scans) were obtained in the 
frequency range 4000 - 1000 cm-1. OMNIC professional software (Thermo Electron 
Corporation, Waltham, MA, USA) was used to determine the peak position. 
 
3.2.6 Statistical Analysis 
The transdermal flux of fluorescein, skin resistance, DSC spectra, and FTIR 
spectra were measured using at least three skin specimens each, from which the mean 
and standard error of the mean were calculated. A two-tailed Student’s t-test (α=0.05) 
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was performed when comparing two different conditions. When comparing three or 
more conditions, a one-way analysis of variance (ANOVA, α=0.05) was performed. 
In all cases, a value p<0.05 was considered statistically significant.  
  
3.3. Results and discussion 
 
3.3.1 Effect of NLS and ethanol concentration on transdermal flux 
     To better understand the mechanism by which NLS increases skin permeability, 
we first measured the effect of NLS concentration on transdermal fluorescein delivery 
across human cadaver skin. Fluorescein is a moderately large (332.31 Da) and 
hydrophilic (octanol-water partition coefficient: logP = -1.22) molecule that serves as 
a model drug that is normally difficult to deliver across the skin. As shown in Figure 
3.1A, accumulated fluorescein delivered across the skin increased approximately 
linearly with time (ANOVA, p<0.05), indicating steady state behavior. The 
accumulated amount delivered over the 5 h experimental period and the 
corresponding skin permeability is shown in Figure 3.1B. These data demonstrate that 
skin permeability increased with increasing NLS concentration (ANOVA, p<0.05) 
and did not show saturation over the range of conditions studied. At the highest NLS 
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Figure 3. 1 Transdermal delivery of fluorescein across human cadaver epidermis 
as a function of NLS concentration. (A) Cumulative fluorescein delivered across 
the skin as a function of time from a formulation containing () 0%, () 1%, 
(▼) 2%, and () 3% (w/v) NLS in 50% (v/v) ethanol. (B) Total fluorescein 
delivered and skin permeability after 5 h as a function of NLS concentration. 
Data were taken from part (A). Data points show the average of n≥3 replicates 





































































47 fold relative to the control sample without NLS (Student’s t test, p<0.01). 
 Because NLS has poor water solubility, the above experiments were carried out 
in an aqueous solution containing 50% ethanol. In addition to increasing NLS 
solubility, the presence of ethanol is also known to increase skin permeability itself. 
We therefore examined the effect of ethanol concentration on transdermal fluorescein 
delivery. As shown in Figures 3.2A and 3.2B, skin permeability exhibited a complex 
dependence on ethanol concentration. In the absence of ethanol, the addition of NLS 
did not significantly enhance skin permeability (0% ethanol without NLS vs. 0% 
ethanol with NLS, Student’s t test, p<0.01). Skin permeability in the presence of NLS 
with 25% and 50% ethanol increased skin permeability by a factor of 20 and 24, 
respectively, relative to the control sample with NLS in 0% ethanol (Student’s t test, 
p<0.01). There was no statistical difference between the permeability measured at 
25% and 50% ethanol (Student’s t test, p>0.05). Skin permeability at 75% and 100% 
ethanol were progressively lower, but were still 6 and 3 times greater, respectively, 
than the control sample with NLS in 0% ethanol (Student’s t test, p<0.05). Altogether, 
we conclude that NLS in the absence of ethanol does not enhance skin permeability, 
NLS with high concentration of ethanol (i.e., 75% or 100% ethanol) is a weak 
enhancer, and NLS with moderate concentration of ethanol (i.e., 25% or 50% ethanol) 
is a strong enhancer.  
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Figure 3. 2 Transdermal delivery of fluorescein across human cadaver epidermis 
as a function of ethanol concentration. (A) Cumulative fluorescein delivered as a 
function of time from a formulation containing 2% (w/v) NLS in () 0%, () 
25%, (▼) 50%, () 75%, and () 100% (v/v) ethanol in PBS or a formulation 
containing () 50% ethanol without NLS. (B) Total fluorescein delivered and 
skin permeability after 5h as a function of ethanol concentration either () with 
or () without 2% NLS. Data were taken from part (A). Data points show the 






































































To facilitate better interpretation, we ran an additional control experiment using 
50% ethanol in the absence of NLS, which can decouple the direct effects of ethanol 
on enhancement from the synergistic effects of ethanol and NLS together. In this case, 
ethanol increased skin permeability by a factor of 3 relative to the control sample 
without ethanol or NLS, but this was not significant (Student’s t test, p=0.08). This 
increase in skin permeability due to ethanol alone was also not statistically different 
from that caused by NLS either in the absence of ethanol or in the presence of 75% or 
100% ethanol (Student’s t test, p>0.1). In contrast, skin permeability in the presence 
of NLS and 25% or 50% ethanol was significantly greater than for 50% ethanol alone 
(Student’s t test, p<0.01). This indicates a synergistic interaction between ethanol and 
NLS, because the sum of the permeability enhancement from NLS alone (non-
significant) and ethanol alone (3 fold) are much less than the enhancement caused by 
their combination (24 fold). 
The reasons for this mechanistic enhancement at 25-50% ethanol concentrations 
will be further investigated below. At 75-100% ethanol concentrations, the reduced 
enhancement may be explained in part by dehydration of the stratum corneum. 
Previous results have shown that exposure to high ethanol concentrations can 
substantially dehydrate the outer layer of the stratum corneum and thereby decrease 
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skin permeability [114]. Dehydration has also been shown to shrink the keratins of the 
stratum corneum, which similarly decreases skin permeability [96].  
 
3.3.2 Skin resistance measurement 
To further validate the synergistic effects of NLS and ethanol of skin barrier 
properties, we examined the effect of ethanol concentration on the electrical resistance 
of skin. Skin’s electrical resistance is generally considered a marker of skin 
permeability and changes in skin resistance due to exposure to different chemical 
enhancers has been shown to correlate with increased skin permeability to model drug 
compounds [115,116]. Moreover, because skin resistance can be easily measured on a 
continuous basis, electrical measurements permit better characterization of the 
kinetics of skin permeability changes.  
 Figure 3.3 A shows skin resistance over time for different formulations. Skin 
samples exposed to 50% ethanol, without NLS, showed a small and insignificant 
(Student’s t test, p>0.1) drop in resistance over the 24-h experimental period. 
However, the combination of NLS and ethanol decreased skin resistance more rapidly 
and to a greater extent, where NLS in 50% ethanol had the greatest effect (Student’s t 
test, p<0.01); NLS in 25 and 75% ethanol had similar, but lesser effects (Student’s t 
test, p<0.01); and NLS in 100% ethanol had much less effect, but still more than the 
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Figure 3. 3 Skin electrical resistance and conductivity as a function of ethanol 
concentration. (A) Normalized electrical resistance of human cadaver epidermis 
treated with a formulation containing 2% NLS in () 0%, () 25%, (▼) 50%, 
() 75%, and () 100% ethanol in PBS and a formulation containing () 50% 
ethanol without NLS. Resistance values were normalized relative to their 
pretreatment levels. (B) Normalized electrical conductivity (i.e., the inverse of 
resistance) of human epidermis after 10 h of treatment () with and () without 
NLS as a function of ethanol concentration. Data were taken from part (A). Data 
points show the average of n≥3 replicates and error bars correspond to the 
standard error of the mean.  
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NLS-only or ethanol-only controls (Student’s t test, p<0.05).  
 Figure 3.3B summarizes these data and replots them as electrical conductivity, 
which is the inverse of electrical resistance and is known to correlate directly with 
skin permeability. [115]  The dependence of changes in skin resistance and 
conductivity on ethanol concentration is strongly consistent with the dependence 
found in measurements of skin permeability to fluorescein (Figure 3.2B), which 
further validates the findings and suggests that these decreases in skin barrier 
properties may be broadly applicable to many drugs.  
 From a mechanistic viewpoint, skin’s electrical resistance is known to be 
governed primarily to the highly ordered, lipophilic barrier of the stratum corneum 
lipid bilayers [117]. Therefore, changes in skin resistance are a sensitive measure of 
changes in stratum corneum lipid bilayer integrity. These measurements suggest that 
the combination of NLS and ethanol act by disrupting stratum corneum lipid bilayer 
structure.  
 A final observation of the skin resistance data concerns the kinetics of action. 
Changes in skin resistance are seen to occur with a lag time of one or more hours 
(Figure 3.3A), which suggests a kinetic barrier that may be a diffusive transport 
limitation. Lag times for transdermal diffusion of small drugs can similarly be a few 
hours  [4], which suggests that the lag time observed for NLS-based enhancement 
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may be limited by the time it takes for NLS to diffuse into and throughout the stratum 
corneum.  
 
3.3.3 Differential scanning calorimetry  
 To further explore the effects of NLS and ethanol on the skin barrier, we are 
guided by the hypothesis that NLS and ethanol increase skin permeability by 
increasing the fluidity of stratum corneum lipid structure. To test this hypothesis, 
DSC was employed to investigate the potential fluidizing effects of NLS in ethanol 
solution on the thermal properties of human stratum corneum (Figure 3.4 and 3.5). 
DSC analysis of negative control samples of human stratum corneum exposed to PBS 
without NLS or ethanol showed two major endothermic transition peaks, Tm1 and Tm2, 
that occur near 75 and 90 oC, respectively. Tm1 is known to correspond to lipid 
structure transformation from a lamellar to disordered state and Tm2 corresponds to 
protein-associated lipid transition from gel to liquid form [118]. It should be 
mentioned that a commonly observed, lower-temperature transition peak (at 35-40 
oC) [100] is not easily observed and an additional transition peak (at 105-120oC), 
representing changes in stratum corneum protein conformation, is also not seen, 
because it requires a skin water content of at least 15% [119] and our stratum 
corneum samples were desiccated before DSC analysis.  
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 The effect of NLS concentration on the thermal profiles of stratum corneum is 
shown in Figures 3.4A and 3.4B. These data show that increasing NLS concentration 
(in the presence of 50% ethanol) significantly decreased both of the transition 
temperatures, Tm1 and Tm2, by as much as 9 and 11
oC respectively (Student’s t test, 
p<0.01). These lipid transitions involve decreased packing order relative to the initial 
state of the stratum corneum, such that the observed decreases in Tm reflect thermal 
transitions starting from less ordered and more fluidized states of stratum 
corneum [120]. These changes in transition temperatures therefore suggest that 
incorporation of NLS into the stratum corneum, with the aid of the ethanol solution, 
leads to increased lipid disorder or fluidization. Moreover, the changes in Tm1 and Tm2 
as a function of NLS concentration scale with the corresponding changes in skin 
permeability (Figure 3.1B), which suggests that increased skin permeability correlates  
the effect of NLS-ethanol mixtures on stratum corneum lipids, DSC analysis                     
showed increased stratum corneum lipid fluidization. To further investigate the 
fluidizing effect of NLS-ethanol mixtures on stratum corneum lipids, DSC analysis 
was performed as a function of ethanol concentration. Figures 3.5A and 3.5B indicate 
that the lipid transition temperatures are reduced by the addition of ethanol and that 
the largest reduction is found at 25% and 50% ethanol (Student’s t test, p<0.01),  
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Figure 3. 4 Differential scanning calorimetry (DSC) analysis of human stratum 
corneum as a function of NLS concentration. (A) DSC thermograms of stratum 
corneum treated with various concentrations of NLS in 50% ethanol and 
negative control thermogram for untreated skin (i.e., no NLS and no ethanol) (B) 
Peak temperature of two characteristic order-disorder transitions associated 
with stratum corneum lipids as a function of NLS concentration () and for the 
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Figure 3. 5 Differential scanning calorimetry (DSC) analysis of human stratum 
corneum as a function of ethanol concentration. (A) DSC thermograms of 
stratum corneum treated with 2% NLS in various concentrations of ethanol and 
control thermogram for 50% ethanol without NLS. (B) Peak temperature of the 
two characteristic transitions as function of ethanol concentration () with NLS 
and () without NLS. Data points show the average of n≥3 replicates and error 





although reductions at 75% and 100% ethanol were also statistically different from 
the 0% ethanol control (Student’s t test, p<0.05).  
     In contrast, when stratum corneum was treated with a 50% ethanol solution 
without NLS, neither of the transition temperatures were shifted (Student’s t test, 
p>0.1). Once again, Figure 3.5A and 3.5B indicate that the lipid transition 
temperatures are reduced by the addition of ethanol and that the largest reduction is 
found at 25% and 50% ethanol these increases in lipid fluidization indicated by lower 
lipid transition temperatures correlate closely with increases in skin permeability 
(Figure 3.2B) and increases in skin conductivity (Figure 3.3B).  
 
3.3.4 Fourier transform infrared spectroscopy  
 To further assess changes in molecular conformations within stratum 
corneum after exposure to NLS and ethanol, we employed FTIR spectroscopy. 
Characteristic peaks are found in FTIR spectra of stratum corneum near 2920 cm-1, 
which corresponds to asymmetric C-H stretching; near 2850 cm-1, which corresponds 
to symmetric C-H stretching; and near 1650 cm-1, which is the amide I band 
corresponding to C-O stretching. The frequencies of the two C-H stretching bands are 
related to lipid order in stratum corneum and are significantly influenced by the 
degree of conformational order, the freedom of alkyl chain motion and possible 
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incorporation of chemical enhancers, such as NLS. The frequency of the C-O 
stretching band is related to stratum corneum protein conformation [121].  
 Representative IR absorbance spectra from 3000-2750 and 1850-1300 cm-1 of 
human stratum corneum samples are displayed in Figures 3.6A,B and 3.9A,B. In 
Figure 3.6A and 3.9A, changes in the C-H stretching region and the amide I band, 
respectively, are shown after treatment of stratum corneum with different NLS 
concentrations. The wave-number position of the three characteristic spectral peaks is 
shown in Figure 3.6B and 3.9B as a function of NLS concentration.  Negative control 
samples exposed to PBS or to 50% ethanol in the absence of NLS both have C-H 
asymmetric, C-H symmetric, and C-O stretching peaks at 2918, 2850 and 1648 cm-1, 
respectively. In contrast, addition of NLS in 50% ethanol increased the wavenumber 
of each of these three peaks by 1 to 4 cm-1 in a dose-dependent manner (Student’s t 
test, p<0.01). Although these wavenumber shifts are relatively small, they are 
statistically significant and are consistent in magnitude with previous studies of 
chemical enhancers [100,122].  
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Figure 3. 6 Fourier transform infrared (FTIR) spectral analysis of human 
stratum corneum lipids as a function of NLS and ethanol concentration. (A) FTIR 
spectra of stratum corneum treated with various concentrations of NLS in 50% 
ethanol. Curves correspond, from top to bottom, to 3% NLS, 2% NLS, 1% NLS, 
and 0% NLS in 50% ethanol, and untreated skin. (B) FTIR spectra of stratum 
corneum treated with 2% NLS in various concentrations of ethanol. Curves 
correspond, from top to bottom, to 100% ethanol, 75% ethanol, 50% ethanol, 
















































































Figure 3. 7 Fourier transform infrared (FTIR) spectral analysis of human 
stratum corneum lipids as a function of NLS and ethanol concentration. Peak 
wavenumber of characteristic spectral peaks corresponding to (1) asymmetric C-
H stretching and (2) symmetric C-H stretching as a function of (C) NLS 
concentration in () 50% ethanol and () in PBS and (D) Ethanol concentration 
() with NLS and () without NLS. Data points show the average of n≥3 














































































Figure 3. 8 Fourier transform infrared (FTIR) spectral analysis of human 
stratum corneum lipids as a function of NLS and ethanol concentration. Peak 
area of characteristic spectral peaks corresponding to (1) asymmetric C-H 
stretching and (2) symmetric C-H stretching as a function of (C) NLS 
concentration in () 50% ethanol and () in PBS and (D) Ethanol concentration 
() with NLS and () without NLS. Data points show the average of n≥3 
replicates and error bars correspond to the standard error of the mean. In (C) 
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Figure 3. 9 Fourier transform infrared (FTIR) spectral analysis of human 
stratum corneum proteins as a function of NLS and ethanol concentration. (A) 
FTIR spectra of stratum corneum treated with various concentrations of NLS in 
50% ethanol. Curves correspond, from top to bottom, to 3% NLS, 2% NLS, 1% 
NLS, and 0% NLS in 50% ethanol, and untreated skin. (B) FTIR spectra of 
stratum corneum treated with 2% NLS in various concentrations of ethanol. 
Curves correspond, from top to bottom, to 100% ethanol, 75% ethanol, 50% 
























































Figure 3. 10 Fourier transform infrared (FTIR) spectral analysis of human 
stratum corneum proteins as a function of NLS and ethanol concentration. 
Wavenumber of spectral peak corresponding to C-O stretching as a function of 
(C) NLS concentration in () 50% ethanol and () in PBS and (D) Ethanol 
concentration () with NLS and () without NLS. Data points show the average 
of n≥3 replicates and error bars correspond to the standard error of the mean. 
 
 
3.3.4.1 Lipid fluidization  
 The increased wavenumber of the two C-H stretching peaks (Figure 3.7A) 
indicates that increasing NLS concentration increased the fluidization of stratum 
corneum lipids, according to established interpretations of FTIR spectra [123]. This 
fluidization could be from dispersed incorporation of NLS among the stratum 




lipids. Comparison with the ethanol-only negative control shows that this was clearly 
the effect of NLS (in the presence of 50% ethanol) and not the effect of ethanol alone. 
This is consistent with previous observations that short-chain alcohols have little 
effect on stratum corneum lipid order below 40 oC  [124] and, despite forming 
localized regions of greater free volume within the lipid alkyl chain regions, exposure 
to ethanol does not cause overall fluidization of stratum corneum lipids [121].  
 
3.3.4.2 Protein conformation  
The increased wavenumber of the C=O stretching peak (Figure 3.10A) indicates 
that increasing NLS concentration also altered stratum corneum protein conformation. 
Closer analysis of Fig. 5B also shows the appearance of an intense new band at 1628 
cm-1 and increased absorption at 1519 cm-1. Altogether, these changes indicate that 
increasing NLS concentration caused a shift from the α-helix protein conformation to 
the β-sheet structure [125]. When considered in the context of skin permeability data 
(Figure 3.1B), this analysis shows that increased skin permeability correlates with 
increased stratum corneum lipid fluidization and altered stratum corneum protein 




3.3.4.3 Effect of ethanol concentration 
We carried out a similar analysis of changes in FTIR spectra for stratum 
corneum samples treated with NLS in different concentrations of ethanol. Changes in 
the C-H stretching region and the amide I band frequencies are shown in Figure 3.6B 
and 3.9B, respectively, and summarized in Figure 3.7B and 3.10B. Treatment of 
stratum corneum with NLS in 25% and 50% ethanol significantly increased the 
wavenumber of all three characteristic spectral peaks relative to the NLS-only and 
ethanol-only control samples (Student’s t test, p<0.05), whereas treatment with NLS 
in 75% and 100% ethanol had much less effect (Student’s t test, p>0.05).  
 
3.3.4.4 Lipid extraction 
     Ethanol and surfactants have been reported to extract lipids from the stratum 
corneum and in that way increase skin permeability [109,126]. To assess the possible 
role of extraction in this study, the area under the two C-H stretching peaks was 
measured as a function of NLS and ethanol concentration. Exposure of skin to 50% 
ethanol significantly decreased the area under both of these peaks (Figure 3.8A,B, 
Student’s t-test, p<0.01), which indicated lipid extraction by ethanol, in agreement 
with previous findings [127]. Addition of NLS in 50% ethanol at progressively larger 
NLS concentration diminished the effect on peak area (Figure 3.8A, ANOVA, 
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p<0.05), which suggests that addition of NLS either reduced the degree to which 50% 
ethanol extracted lipids or that NLS possibly replaced the extracted lipids and thereby 
increased the peak area. At constant NLS concentration, increasing ethanol 
concentration progressively decreased peak area for both lipid peaks (Figure 3.8B, 
ANOVA, p<0.01), which indicated that higher ethanol concentrations increased lipid 
extraction.  
Notably, the dependence of peak area on NLS and ethanol concentration is 
different from that of skin permeability. For example, the addition of 50% without 
NLS caused a large drop in peak area, but had no effect on skin permeability. 
Moreover, increasing ethanol concentration (in combination with NLS) progressively 
decreased peak area, but caused skin permeability to go through a maximum at 25 – 
50% ethanol. These different functionalities of lipid extraction measured by peak area 
and skin permeability indicated that although lipid extraction may have occurred, it 
was not responsible for the observed increases in skin permeability.   
Altogether, these observations indicate that NLS in the presence of 25-50% 
ethanol increases lipid fluidization and alters protein conformation (Figure 3.7B and 
3.10B), which correlates with dramatically increased skin permeability (Figure 3.2B). 
NLS in the presence of 75-100% ethanol had little effect on lipid fluidity and protein 
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conformation in stratum corneum, which similarly correlates with the modest 
increases in skin permeability seen under those conditions. 
 
3.3.5 Discussion 
 The results of this study show a remarkably consistent correlation between four 
different analyses of skin properties as a function of NLS and ethanol concentration. 
Consistently, treatment using NLS without ethanol or ethanol without NLS had little 
to no significant effect on skin permeability to fluorescein, skin electrical resistance, 
DSC thermograms, and FTIR spectra. In contrast, the combination of NLS and 
ethanol at an optimized concentration of 25-50% uniformly increased skin 
permeability, decreased skin resistance, decreased DSC transition temperatures, and 
increased FTIR peak wavenumbers.  
 Interpretation of these findings demonstrates a correlation, and suggests a 
causative relationship, between increased skin permeability and increased stratum 
corneum lipid fluidization, as well as changes in protein conformation. We 
hypothesize that NLS inserts into the stratum corneum lipid structures with the aid of 
ethanol, which disrupts the lipid packing. NLS alone may have difficulty partitioning 
into the stratum corneum lipid domain and ethanol alone is known not to affect lipid 
fluidity. However, the combination of NLS and ethanol has a synergistic effect, such 
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that ethanol may facilitate penetration of NLS into the stratum corneum lipids, where 
NLS is then able to fluidize lipid structure.  
 Although we observed changes in protein conformation as well, we do not expect 
that these changes are mechanistically responsible for the skin’s increased 
permeability. Skin’s barrier properties have been widely established to reside 
predominantly in the stratum corneum lipids, where stratum corneum proteins play a 




 This study sought to determine the mechanism by which mixtures of NLS and 
ethanol increase transdermal transport by testing the hypothesis that NLS and ethanol 
synergistically increase skin permeability by increasing the fluidity of stratum 
corneum lipid structure. When NLS in 50% ethanol was applied to human cadaver 
skin over a range of NLS concentrations, skin permeability to fluorescein was 
increased by up to 47 fold in a manner that depended strongly on NLS concentration. 
Ethanol concentration also strongly affected skin permeability, where formulations 
containing NLS in 25% and 50% ethanol dramatically enhanced transdermal delivery, 
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whereas NLS in 0%, 75%, and 100% ethanol had modest or no effect. Ethanol in the 
absence of NLS had only a small effect on skin permeability.  
 The degree of skin permeability enhancement correlated with companion 
measurements of skin electrical resistance, which is a general measurement of skin 
barrier function associated with an intact stratum corneum lipid domain. Increased 
skin permeability also correlated with altered DSC transition temperatures and FTIR 
peak shifts that indicate increased fluidity of the stratum corneum lipids and changes 
in protein conformation from the α-helix to the β-sheet structure. These correlations 
suggest a causative relationship in which increased lipid fluidity is the mechanism by 
which combinations of NLS and an aqueous ethanol solution increase skin 
permeability. This formulation also appeared to cause extraction of stratum corneum 
lipids, but the level of extraction did not correlate with skin permeability changes, 
which suggested it was a secondary effect. Finally, the synergistic effect of this 
formulation may result from the ability of the ethanol solution to improve the 
permeation of NLS in the lipid bilayer matrix of the stratum corneum, thereby 
improving the ability of NLS to disrupt the lipid order. 
 Overall, we conclude that a mixture of NLS in 25-50% ethanol acts synergistically 
to increase skin permeability. This formulation may be useful for transdermal drug 
delivery applications.   
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CHAPTER 4: TRANSDERMAL DELIVERY ENHANCED 





 Transdermal delivery is an attractive method to administer drugs that avoids 
the pain of injection, reduces the enzymatic degradation associated with oral delivery, 
and facilitates sustained delivery for up to many days  [4]. However, drug delivery 
into the skin is severely limited by the barrier properties of the stratum corneum, 
which is the outermost layer of skin. The stratum corneum is composed of keratin-
filled, non-viable cells (corneocytes) embedded in a crystalline intercellular lipid 
domain. These intercellular lipids compose the continuous domain of the stratum 
corneum and provide its primary barrier properties. Stratum corneum lipids consist of 
an approximately equimolar mixture of free fatty acids, cholesterol and 
ceramides  [21].  
   Numerous methods have been suggested to overcome the skin barrier for 
transdermal drug delivery. Chemical penetration enhancement methods have received 
the most attention, where addition of various chemical agents, such as fatty acids, 
fatty esters, alcohols, terpenes, pyrrolidones, sulfoxides, and surfactants, has been 
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tested to increase skin permeability  [106].  However, few have succeeded in 
delivering drugs at therapeutic rates without causing skin irritation or damage. 
Physical approaches, such as iontophoresis  [130], electroporation  [131] 
ultrasound  [4], and microneedles  [57], have also been evaluated. 
   In this study, we hypothesize that magainin, a peptide known to form pores in 
bacterial cell membranes, can increase skin permeability by disrupting stratum 
corneum lipid structure. A variety of pore-forming peptides are found in nature and 
have been the subject of intensive research due to their potential application as novel 
antibiotics  [132]. One of the most studied is magainin, which is a 23 amino acid 
peptide isolated from the skin of the African clawed frog, Xenopus laevis  [68]. This 
amphiphilic and non-hemolytic peptide has been shown to kill bacteria by perturbing 
the membrane function responsible for cellular osmotic balance by self-assembling in 
the cell membrane to form transmembrane pores  [71,133]. Human clinical trials 
showed that a magainin derivative, Pexiganan, was developed for the intended 
application to infected diabetic foot ulcers  [134]. Other studies have suggested that 
magainin might be used for contraception  [135] and treatment of cancer  [136]. 
 To assess the possibility that magainin can increase skin permeability for 
transdermal drug delivery, our previous work showed that magainin disrupts liposome 
vesicles made from lipids representative of those found in human stratum 
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corneum  [137]. Encouraged by those results, in this study we measured skin 
permeability after exposure to various magainin formulations and then carried out 
additional mechanistic analysis using Fourier-transform infrared spectroscopy, X-ray 
diffraction, and differential scanning calorimetry to characterize the interactions 
between magainin and stratum corneum lipids.  
 
4.2. Materials and Methods 
 
4.2.1 Skin preparation 
Same as Chapt 3. 
  
4.2.2 Skin permeability measurement  
 Same as Chapt 3. 
 
4.2.3 Skin imaging by multi-photon microscopy 
   To image fluorescein and magainin distribution in the skin, skin was 
pretreated for 15 h as described above, except that sulphorhodamine-tagged magainin 
peptide (Microchemical and Proteomics Facility, Emory University) was used. 
Fluorescein was delivered across the skin, as described above, for 1 h. The skin 
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sample was then removed from the Franz cell and placed on a glass coverslip. Skin 
imaging was carried out using a multi-photon microscope (Zeiss LSM/NLO 510, 
Oberkochen, Germany) with a water immersion lens an oil-immersion lens of 40× 
magnification to collect “z-stack” optical slices at a series of depths into the epidermis.  
 
4.2.4 Imaging of histological skin sections 
  To image microscale stratum corneum organization, a 2 cm × 2 cm piece of full-
thickness skin was pretreated as described above and then cut into 4 mm × 7 mm 
pieces and placed in a cryoblock with optimal cutting temperature compound (Tissue-
Tek, Sakura Finetek, Torrance, CA, USA). After freezing in liquid nitrogen, skin was 
sectioned on a cryostat (Cryo-star HM 560MV, Microm, Waldorf, Germany) at 40-μ
m thickness and placed on a glass slide. 
  To help with imaging the stratum corneum, the skin sections were swelled by 
applying a drop of half-strength Sorensen-Walbum buffer (0.1 N sodium hydroxide 
solution and 0.1 N glycine solution; Sigma Aldrich) to the tissue for 15 min  [138]. 
Then, a stock solution containing 0.05% (w/v) Nile Red (Molecular Probes, Eugene, 
OR, USA) in acetone was diluted to 2.5 μg/ml with 75:25 (v/v) glycerol:water and 
vigorously mixed on a vortexer. A drop of the resulting Nile Red solution was applied 
on each sample, which was then sealed beneath a cover slip using transparent nail 
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polish (Revlon, New York, USA)  [138] and imaged by a multi-photon microscope 
(Zeiss LSM/NLO 510). 
 
4.2.5 Fourier-transform infrared spectroscopy 
   Same as Chapt 3.  
 
4.2.6 X-ray diffraction 
   Stratum corneum samples were pretreated with enhancer formulations as 
described above, desiccated under vacuum, and then hydrated for 10 min before 
examination. The wide-angle X-ray diffraction (PANalytical, Almelo, Netherlands) 
was carried out at 40 mA and 45 kV and small-angle X-ray diffraction (Rigaku 
DMAX 2500, Tokyo, Japan) was carried out at 300 mA and 50 kV.  
  
4.2.7 Differential scanning calorimetry 
   Same as Chapt 3. 
 
4.2.8 Statistical Analysis 
     Skin permeability to fluorescein, FTIR spectroscopy, and DSC were measured 
using at least three replicate skin samples at each condition, from which the mean and 
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standard error of the mean were calculated. A two-tailed Student’s t-test was 
performed when comparing two different conditions. When comparing three or more 




4.3.1 Effect of magainin formulations on skin permeability 
 Our previous results showed that incubation with magainin peptide could 
disrupt vesicles made from lipids representative of those found in human stratum 
corneum  [137]. This suggested that magainin could disrupt stratum corneum lipids in 
the skin and thereby increase skin permeability. To test this idea, we exposed human 
skin to a magainin solution, but there was no change in skin permeability to a model 
compound, fluorescein (Figure 4.1, Student’s t-test, p=0.35). To explain this result, 
we hypothesized that magainin has the ability to insert into a single bilayer, such as 
that found in a bacterial cell or a liposome vesicle, but may not have a mechanism to 
cross over additional bilayers, especially given magainin’s large size (2494 Da). 
Because there are close to 100 multilamellar lipid bilayers in a cross section of  
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Figure 4. 1 Effect of magainin formulations on skin permeability. (A) 
Cumulative fluorescein delivered across human cadaver skin pre-treated with 
(●) no treatment, () magainin peptide in PBS, (○) 50% ethanol, () NLS in 
50% ethanol and (■) NLS and magainin peptide in 50% ethanol.(B) Skin 
permeability values determined from part (A). Data represent averages of n≥3 
samples with standard error of the mean. The * symbol identifies permeabilities 
significantly greater than untreated skin (Student’s t-test, p<0.05). The + symbol 
identifies permeabilities after magainin exposure significantly greater than 













































stratum corneum, the ability to cross multiple bilayers is essential to increase skin 
permeability. 
     To address this problem, we added a well-known anionic surfactant enhancer – 
N-lauroyl sarcosine (NLS) – in 50% ethanol solution to facilitate magainin 
penetration throughout the stratum corneum. We used this formulation, because our 
previous study showed that NLS in 50% ethanol is a good skin permeation 
enhancer  [139]. As shown in Figure 4.1, this magainin-NLS-ethanol combination 
yielded a 47-fold increase in skin permeability (Student’s t-test, p<0.01), which shows 
that magainin can increase skin permeability.  
Moreover, the enhancement by magainin-NLS-ethanol was significantly 
greater than the 15-fold increase caused by NLS in ethanol (without magainin) 
(Student’s t-test, p<0.01) or the 1.3 fold increase caused by ethanol (without magainin 
or NLS) (Student’s t-test, p=0.077). Because the enhancement of the magainin-NLS-
ethanol combination is three-fold greater than the sum of the enhancements by the 
individual components, this synergy suggests an interaction between magainin and 
NLS-ethanol and is consistent with the hypothesis that NLS-ethanol increased 
magainin penetration into skin, which in turn allowed magainin to further disrupt lipid 















Figure 4. 2 Effect of chemical enhancers on skin permeability and interaction 
with magainin. Skin permeability to fluorescein after pre-treatment with an 
enhancer alone (black bars) or in combination with magainin (white bars) for 
different enhancers: (A) no chemical enhancer, (B) N-lauroyl sarcosine, (C) cetyl 
trimethyl ammonium bromide, (D) sorbitan monolaurate, (E) oleic acid, (F) 
isopropyl myristate and (G) phenyl piperazine, all in 50% ethanol. Data 
represent averages of n≥3 samples with standard error of the mean. The * 
symbol identifies permeabilities significantly greater than untreated skin 
(Student’s t-test, p<0.05). The + symbol identifies permeabilities after magainin 




 To determine if other chemical enhancer formulations might similarly act 
synergistically with magainin, we compared NLS to five other enhancers from 
different chemical classes, including a cationic surfactant (cetyl trimethyl ammonium  
bromide), nonionic surfactant (sorbitan monolaurate), fatty acid (oleic acid), fatty 


















in Figure 4.2, only NLS and the cationic surfactant directly increased skin 
permeability to fluorescein (conditions B and C, Student’s t-test, p<0.01) and only 
NLS showed a synergistic increase in skin permeability with magainin (condition B, 
Student’s t-test, p=0.046). The fact that magainin carries a positive charge and NLS 
carries a negative charge suggests that the ionic attraction between these compounds  









Figure 4. 3 Penetration of sulforhodamine-tagged magainin peptide into human 
epidermis imaged by multi-photon microscopy. Magainin formulated (A) 
without NLS and (B) with NLS, both in 50% ethanol. Optical sections taken at 5 
µm increments starting at the stratum corneum surface on the left and 
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Figure 4. 4 Penetration of fluorescein and sulforhodamine-tagged magainin 
peptide into human epidermis imaged by multi-photon microscopy. Fluorescein 
formulated with (A) PBS, (B) with NLS in 50% ethanol and (C) with NLS and 
magainin in 50% ethanol. Green corresponds to fluorescein, red corresponds to 
sulforhodamine-tagged magainin and yellow corresponds to co-localization of 
fluorescein and magainin. Optical sections take at 5 µm increments starting at 
the stratum corneum surface on the left and proceeding deeper on the right. 
Scale bar is 100 µm.  
 
 
4.3.2 Imaging magainin and fluorescein penetration into skin  
     To more directly test the hypothesis that NLS-ethanol increases magainin 
penetration into skin, we imaged the skin by multi-photon microscopy after delivery 
of sulforhodamine-labeled magainin with and without NLS-ethanol enhancement. As 
shown in Figure 4.3A, very little magainin (red fluorescence) was able to enter the 





NLS-ethanol, magainin was able to penetrate throughout the 10–15 µm layer of 
stratum corneum.  
 Figure 4.4 shows complementary data that simultaneously image magainin 
(red fluorescence) and fluorescein (green fluorescence) transport into the skin. In the 
absence of NLS-ethanol and magainin, there is little fluorescein delivery into the skin 
(Figure 4.4A). The addition of NLS-ethanol significantly increased fluorescein 
delivery (Figure 4.4B), in agreement with skin permeability data in Figure 4.1. Finally, 
the combination of NLS-ethanol and magainin increased fluorescein delivery even 
more and was associated with significant magainin penetration into the stratum 
corneum (Figure 4. 4C). It is interesting to note that there is significant co-localization 
of magainin and fluorescein (indicated by yellow in Figure 4.4C), which is consistent 
with magainin-mediated disruption of the stratum corneum corresponding to 
pathways for increased fluorescein transport. It is also worth noting that magainin 
preferentially localized within the stratum corneum, which is consistent with its 
expected mechanism of preferentially inserting into stratum corneum lipid bilayers, 
whereas fluorescein penetrated deeply into the skin.  
 These observations provide direct evidence that increased magainin 
penetration into the stratum corneum is associated with increased skin permeability 






















Figure 4. 5 Fourier-transform infrared spectroscopy analysis of human stratum 
corneum treated with different formulations. Spectra of wavenumbers 
characteristic of (A) C-H stretching in lipids and (B) C-O stretching in proteins 
treated with (from bottom to top): PBS, magainin in PBS, 50% ethanol, NLS in 
50% ethanol, NLS and magainin in 50% ethanol. Dashed lines indicated peaks of 









































































Figure 4. 6 Fourier-transform infrared spectroscopy analysis of human stratum 
corneum treated with different formulations. Change of (1) CH2 asymmetric 
stretching frequency, (2) CH2 symmetric stretching frequency and (3) CO 
stretching frequency, determined from graphs in Figure 4.5 (A) and (B). Data 
represent averages of n≥3 samples with standard error of the mean. The * 
symbol identifies wavenumbers significantly greater than untreated skin 
(Student’s t-test, p<0.05). The + symbol identifies wavenumbers after exposure to 
NLS and magainin that are significantly greater than exposure to just NLS 
(Student’s t-test, p<0.05). 
 
not only helps elucidate the mechanism of skin permeability enhancement, but also 
introduces the novel concept of using a first chemical enhancer to increase delivery of 







4.3.3 Fourier-transform infrared spectroscopy 
 Because magainin and NLS-ethanol are hypothesized to disrupt stratum 
corneum lipid structure, we characterized stratum corneum samples exposed to 
different formulations using Fourier-transform infrared (FTIR) spectroscopy. To 
identify alterations in lipid order, we measured changes in carbon-hydrogen stretching  
frequencies near 2850 and 2920 cm-1, which are due to symmetric [vs(CH2)] and 
asymmetric [vas(CH2)] C-H stretching in stratum corneum lipid molecules, 
respectively (Fig. 5A)  [123]. To identify alteration in protein structure, we also 
measured changes in the carbon-oxygen stretching frequency near 1650 cm-1 [v(CO)], 
which is associated with transitions from α-helix to β-sheet structure of stratum 
corneum keratin molecules (Figure 4.5B)  [121].  
 As summarized in Figure 4.6, stratum corneum treated with magainin alone 
or 50% ethanol alone did not cause significant changes in any of the three 
characteristic stretching frequencies (Student’s t-test, p>0.05). In contrast, treatment 
with NLS-ethanol caused an increase in νas(CH2) of 2.6 cm
-1 and  νs(CH2) of 0.85 cm
-1 
relative to untreated skin (Student’s t-test, p<0.05). Addition of magainin peptide 
raised these stretching frequency values even higher to increases in νas(CH2) of 4.3 
cm-1 and νs(CH2) of 1.2 cm
-1. These increases in the presence of magainin are 
























































Figure 4. 7 X-ray scattering analysis of human stratum corneum treated with 
different formulations. (A) Wide-angle and (B) small-angle X-ray scattergrams 
of stratum corneum treated with PBS (control), NLS in 50% ethanol or NLS and 
magainin in 50% ethanol. Dashed lines indicate peaks of interest. Graphs are 






treated only with NLS-ethanol (Student’s t-test, p<0.1). These data indicate that NLS-
ethanol increased stratum corneum lipid chain disorder and fluidity and that addition 
of magainin caused a further increase in this disorder.  
 Protein structure was also affected by NLS-ethanol and magainin. Treatment 
with NLS-ethanol caused an increase in ν(CO) of 1.1 cm-1 relative to untreated skin 
(Student’s t-test, p=0.028). Addition of magainin peptide raised ν(CO) even higher to 
increases of 2 cm-1, which are significantly different from untreated skin (Student’s t-
test, p=0.002) and from skin treated only with NLS-ethanol (Student’s t-test, p=0.091). 
These data indicate that NLS-ethanol and magainin also have effects on stratum 
corneum proteins, possibly promoting a transformation from the α-helix to the β-sheet 
structure. 
 
4.3.4 X-ray diffraction 
 To further elucidate effects on stratum corneum structure, we used wide-
angle and small-angle X-ray diffraction (XRD) to provide a direct measure of changes 
in lipid bilayer packing. Wide-angle XRD on untreated skin revealed a characteristic 
peak at 16.7 Å caused by scattering of crystalline cholesterol  [102], which is a 
primary component of stratum corneum lipids (Figure 4.7A). Treatment with NLS-
ethanol reduced this peak and addition of magainin reduced it still farther. This 
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suggests that both NLS-ethanol and magainin reduced cholesterol crystallinity, which 
reduces lipid bilayer order.  
 Small-angle XRD on untreated skin revealed a number of characteristic peaks, 
notably corresponding to ceramides (d = 6.13 nm) and crystalline cholesterol (d = 
3.38 nm)  [140]. Treatment with NLS-ethanol reduced both the ceramide and 
crystalline cholesterol peaks and addition of magainin reduced them still farther. 
(Figure 4.7B). This further suggests that both NLS-ethanol and magainin disrupt the 
order of the dominant components of stratum corneum lipid bilayer structures.   
 
4.3.5 Differential scanning calorimetry 
     Differential scanning calorimetry (DSC) provides another method to probe 
changes in stratum corneum structure, based on its thermal properties. DSC analysis 
of untreated dry human stratum corneum showed two major thermal transitions, T1 
and T2, at approximately 75 and 90 
oC, respectively (Figure 4.8). T1 is assigned to 
lipid structure transformation from lamellar to the disordered, and T2 is assigned to a 
protein-associated lipid transition from gel to liquid form  [118]. Other previously 
reported transition peaks at 35-40 oC and 105-120 oC were not seen here, in part 


































































Figure 4. 8 Differential scanning calorimetry (DSC) analysis of human stratum 
corneum treated with different formulations. (A) Thermograms of stratum 
corneum treated with (from top to bottom): PBS (control), magainin in PBS, 
50% ethanol, NLS in 50% ethanol, NLS and magainin in 50% ethanol. Arrows 
indicate peaks of interest. Graphs are representative of n≥3 replicate samples. 
(B) Changes of two characteristic transition midpoint temperatures (T1: , T2: 
) determined from graph in (A). Data represent averages of n≥3 samples with 
standard error of the mean. The * symbol identifies temperatures significantly 




     As summarized in Figure 4.8B, stratum corneum treated with magainin alone or 
50% ethanol alone did not cause significant changes in either of the major thermal 
transitions (Student’s t-test, p>0.1). In contrast, after treatment with NLS-ethanol, the 
first and second transition temperatures were decreased by 9 and 10.5 oC, respectively, 
relative to untreated skin (Student’s t-test, p<0.01). Addition of magainin further 
dropped these transition temperatures to decreases of 10 and 11.5 oC, 
respectively (Student’s t-test, p<0.01), but these changes were not significantly 
different from skin treated only with NLS-ethanol (Student’s t-test, p>0.1). Altogether, 
the decreased lipid transition temperatures indicate that NLS-ethanol disordered 
stratum corneum lipids, but that addition of magainin did not further disorder lipids at 
detectable levels. The effects of magainin may not have been evident through DSC 
analysis because DSC measures bulk properties that are relatively insensitive to 
localized changes. Unlike NLS-ethanol, which can fluidize throughout the stratum 
corneum lipids, magainin’s mechanism of action is expected to be in the form of 
transmembrane pore structures localized on the nanometer scale.  
 
4.3.6 Stratum corneum histology 
 As a final assessment of changes to stratum corneum structure, skin was 
cryo-sectioned, stained and imaged histologically after exposure to different  
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Figure 4. 9 Changes in human stratum corneum architecture imaged by multi-
photon microscopy of histological cross-sections. Stratum corneum was treated 
with (A) PBS, (B) NLS in 50% ethanol and (C) NLS and magainin in 50% 
ethanol. To facilitate imaging, stratum corneum was swelled by incubation in 
Sorensen-Walbum buffer and stained with Nile Red. Scale bar is 20μm.  
 
formulations. As displayed in Figure 4.9A, untreated stratum corneum showed intact, 
densely packed structure. In contrast, stratum corneum treated with NLS-ethanol 
alone (Figure 4.9B) or with magainin peptide (Figure 4.9C) showed disruption and 
expansion of the stratum corneum layers consistent with a loss of lipid structural 
order. Differences between stratum corneum treated with or without magainin peptide 
were, once again, not evident, perhaps because localized, nanometer-scale pore 









4.4.1 Magainin can increase skin permeability by disrupting stratum corneum lipid 
structure 
 This study investigated the application of a pore-forming peptide, magainin, 
as a novel transdermal transport enhancer. Toward this end, we tested the hypothesis  
that magainin, a peptide known to form pores in bacterial cell membranes, can 
increase skin permeability by disrupting stratum corneum lipid structure. In support of 
this hypothesis, a magainin-based formulation was shown to increase skin 
permeability to fluorescein by 47 fold (Figure 4.1). The mechanism of disrupting 
stratum corneum lipid structure was supported by multi-photon microscopy imaging, 
shifted FTIR peak position related to lipid and protein stretching frequencies, and 
reduced X-ray diffraction peak intensities related to lipid structure. 
 Multi-photon microscopy showed significant magainin penetration into the 
stratum corneum, but not into the viable epidermis (Figures 4.3 and 4.4). This 
indicates that the site of action is located in the stratum corneum. Although magainin 
appears to be localized both intracellularly and extracellularly in the stratum corneum, 
fluorescein appears to be located primarily extracellularly (i.e., within the 
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extracellular lipids). This indicates that the site of magainin action to increase skin 
permeability was located in the extracellular lipids. 
    FTIR spectroscopy showed a disruption of stratum corneum lipid and protein 
structure induced by magainin (Figure 4.5 and 4.6). Moreover, for the various 
formulations used, the degree of structural disruption measured by FTIR correlated 
with the increase in skin permeability measured by fluorescein delivery, which 
suggests a mechanistic relationship. Disruption of lipid acyl chain order was indicated 
by an increase of C-H stretching absorbances to higher wavenumbers  [123]. Protein 
order was also disrupted, as indicated by an increase in C-O stretching consistent with 
conformational transformation of keratin from the α-helix to the β-sheet 
structure  [121]. This conformational change of keratin may be a secondary effect of 
the disruption of stratum corneum lipid structure  [142].  
X-ray scattering analysis also indicated a disruption of stratum corneum lipid 
structure induced by magainin (Figure 4.7). Again, there was a dose-response effect, 
where formulations that caused greater structural disruption corresponded to increased 
skin permeability. Wide-angle and small-angle XRD showed reduced peak intensity 
associated with crystalline cholesterol. Cholesterol is the second most abundant lipid 
in the stratum corneum and its role is recognized as providing plasticity in the gel-
phase bilayer  [143]. On a related note, it has been observed that changes in 
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cholesterol metabolism in the epidermis leads to a disturbed barrier function of 
skin  [15]. Our formulations containing NLS-ethanol and magainin are hypothesized 
to increase skin permeability in part by removing or reducing the cholesterol in 
stratum corneum. Previous work has shown that other anionic surfactants, sodium 
lauryl sulfate and lauroyl isothionate, extract cholesterol from stratum corneum cell 
membranes  [144]. Small-angle XRD also showed reduced peak intensity associated 
with ceramides, which is also one of the most abundant lipids in stratum corneum.  
DSC analysis showed changes in the thermal profile of stratum corneum after 
treatment with NLS-ethanol that was indicative of increased lipid fluidity. However, 
further changes in the thermal profile due to addition of magainin were not 
statistically significant.  
 
4.4.2 Magainin’s enhancement requires co-administration with a surfactant chemical 
enhancer to increase magainin penetration into the skin 
Although magainin was previously shown to disrupt liposome vesicles made 
of lipids representative of stratum corneum  [137], magainin without a chemical 
enhancer had no effect on skin permeability in this study (Figure 4.1). This could be 
explained by the ability of magainin to inserted into and disrupt an individual lipid 
bilayer, but an inability to cross over multiple bilayers, such as the multilamellar 
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stacks of lipids found in stratum corneum. Guided by this, we hypothesized that 
magainin’s enhancement requires co-administration with a surfactant chemical 
enhancer to increase magainin penetration into the skin.  
  Consistent with this hypothesis, co-administration of magainin and an anionic 
surfactant, NLS, in a 50% ethanol formulation increased skin permeability 47 fold. In 
contrast, NLS-ethanol without magainin increase skin permeability just 15 fold 
(Figure 4.1). This synergistic effect indicated an interaction between NLS and 
magainin. Multi-photon microscopy supported this, by showing that without NLS-
ethanol, little magainin penetration into the skin occurred, but co-administration of 
magainin and NLS-ethanol led to extensive magainin penetration throughout the 
stratum corneum (Figure 4.3). Comparison to fluorescein transport data (Figures 4.1 
and 4.4) showed that increased magainin penetration into stratum corneum correlated 
with increased skin permeability.  
In addition to NLS, five other kinds of chemical enhancers were evaluated, 
but only the anionic surfactant NLS was found to act synergistically with magainin. 
This could be because of an ionic attraction between negatively charged NLS and 
positively charged magainin that facilitates penetration and interaction with the 
stratum corneum. It also might be explained based on an interaction between NLS and 
skin that makes stratum corneum especially permeable and thereby, in a nonspecific 
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way, increases magainin penetration into stratum corneum. This latter argument is 
supported by the observation that, without magainin, NLS increased skin permeability 




 This study showed that a formulation containing a pore-forming peptide, 
magainin, and NLS in 50% ethanol synergistically increased skin permeability by 47 
fold. Analysis by multi-photon microscopy, FTIR, XRD, and DSC supported the 
hypothesis that magainin can increase skin permeability by disrupting stratum 
corneum lipid structure, especially ceramides and cholesterol. Additional analysis 
supported the hypothesis that magainin’s enhancement requires co-administration 
with a surfactant chemical enhancer to increase magainin penetration into the skin  
   Overall, we conclude that the combination of magainin and NLS-ethanol 
synergistically increases skin permeability, because NLS-ethanol increased magainin 
penetration into stratum corneum, which further increased stratum corneum lipid 
disruption and skin permeability. We believe this is the first study to use a pore-
forming peptide as a skin penetration enhancer and the first study to use one chemical 
enhancer to increase penetration of another chemical enhancer into the skin. 
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CHAPTER 5: OPTIMIZATION OF TRANSDERMAL 





   Multilamellar lipid bilayers comprise the continuum portion around the corneocyte 
cells of stratum corneum, which is the primary barrier in skin  [145]. Various 
physical and chemical methods have been tested to increase the permeability of the 
stratum corneum to drugs, which could enable transdermal delivery of more drugs 
using a transdermal patch. However, few methods have succeeded to deliver relevant 
agents at the appropriate flux levels without causing skin irritation or damage  [4].  
This study addresses the use of a naturally occurring pore-forming peptide, 
magainin, to increase skin permeability. Magainin is a 23-residue helical peptide 
isolated from the skin of the African frog, which exhibits a broad spectrum of 
antimicrobial activity properties. It has a net +4 charge and binds to negatively 
charged phospholipid membranes with the aid of electrostatic interactions, forming an 
amphiphilic helix and permeabilizing the bilayers  [64,68].  
 Our previous work shows that the use of magainin disrupts vesicles that are made 
from lipid bilayer components representative of those found in human stratum 
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corneum  [137], and that magainin administered in a formulation containing an 
anionic surfactant, N-lauroyl sarcosine (NLS), in 50% ethanol-in-PBS synergistically 
increased skin permeability. Mechanistic analysis using differential scanning 
calorimetry, Fourier-transform infrared spectroscopy, and X-ray diffraction suggested 
that magainin and NLS can increase skin permeability by disrupting stratum corneum 
lipid structure  [146].  
Building off the results of our previous work, this study sought to further 
optimize conditions that increase skin permeability. Because the interaction between 
magainin and the stratum corneum is critical to the enhancement mechanism, we 
varied the pretreatment time and magainin concentration during exposure to skin. We 
also tested the effect of molecular weight of delivered molecules on skin permeability.   
 
5.2. Experimental methods 
 
5.2.1 Skin preparation and permeability measurement 
    Human epidermis (Emory University) was isolated from dermis using the heat 
separation method  [113]. Before measuring skin permeability, skin was pretreated 
with magainin and other control formulations. Epidermis was placed in a vertical, 
glass Franz diffusion cell apparatus (PermeGear) with 0.7 cm2 exposed skin surface 
area. The receiver chamber was filled with PBS and the donor chamber was filled 
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with 0.3 ml of a formulation in PBS containing 50% (v/v) ethanol, 2% (w/v) N-
lauroyl sarcosine (Fluka) and, sometimes, 1 mM magainin peptide (Emory 
University). After a 0-12 h exposure to one of these formulations at 4 oC, the Franz 
cell was transferred to a heater/stirrer block (PermeGear) maintained at 32 oC and 
stirred at 455 rpm for 3 h. 
 After this pretreatment, the receiver chamber was emptied and filled with fresh 
PBS and the donor chamber was emptied and filled with 0.3 ml of 1 mM fluorescein, 
calcein (Sigma Aldrich), or fluorescein-tagged dextran (3000 Da, Molecular Probes) 
in PBS. Every hour for 5 h, the receiver chamber was sampled. Samples were 
analyzed by calibrated spectrofluorimetry (Photon Technologies International) to 
determine transdermal flux and permeability. 
 
5.2.2 Skin imaging by multi-photon microscopy 
    To image fluorescein and magainin distribution in the skin, skin was pretreated 
with sulforhodamine-tagged magainin. Fluorescein was then delivered across the skin, 
as described above, for 1 h. The skin sample was then removed from the Franz cell 
and placed on a glass cover slip. Skin imaging was carried out using a multi-photon 
microscope (Zeiss LSM/NLO 510) with an oil-immersion lens of 40× magnification 
to collect “z-stack” optical slices at a series of depths into the epidermis.  
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5.3. Results and discussion 
 
To further optimize conditions that enhance skin permeability by magainin, we 
studied the effect of the duration and concentration of magainin exposure during 
pretreatment of the skin and the effect of the molecular weight of delivered molecules 
on skin permeability. 
We first hypothesized that increased magainin pretreatment exposure time 
should increase skin permeability to fluorescein by enabling more magainin to enter 
the stratum corneum. As shown in Figure 5.1A, the amount of fluorescein delivered 
across the skin increased when we increased the pretreatment time (ANOVA, p<0.01). 
The black bars in Fig. 1-a show the increase in skin permeability caused by incubation 
with the formulation of NLS in 50% ethanol-in-PBS without magainin. This 
formulation alone increases skin permeability (ANOVA, p<0.01). The white bars 
show the increase in skin permeability caused by incubation in the same formulation 
that also contained magainin (ANOVA, p<0.01). The addition of magainin further 
increased skin permeability beyond that of the magainin-free formulation after 12 h 
(ANOVA, p<0.05). 
 Further examination shows that the permeability increase after 3 h was 
insignificant (Student’s t-test, p>0.05), whereas the permeability increases after 6 h 
and longer were significant (Student’s t-test, p<0.01). This led us to conclude 
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Figure 5. 1 (A) Effect of pretreatment time on the enhancement of skin 
permeability to fluorescein for skin treated without (■) and with (□) magainin. 
The enhancement ratio is defined as the skin permeability at the condition tested 
divided by the permeability of untreated skin. (B) Penetration of fluorescein and 
sulforhodamine-tagged magainin peptide into human epidermis imaged by 
multi-photon confocal microscopy. Skin was treated with magainin formulation 
for (1) 1 h, (2) 4 h, and (3) 12 h. Green corresponds to fluorescein, red 
corresponds to sulforhodamine-tagged magainin, and yellow corresponds to co-
localization of fluorescein and magainin. Optical sections taken at 5 µm 
increments starting at the stratum corneum surface on the left and proceeding 
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Figure 5.2 Concentration effect of magainin peptide. (A) Transdermal 
fluorescein skin permeability enhancement ratio (All sample treated with NLS) 
(B) Fourier transform infrared (FTIR) spectral analysis of human stratum 
corneum. Peak wavenumber of characteristic spectral peaks corresponding to  
asymmetric C-H stretching and  symmetric C-H stretching as a function of 
magainin concentration. Data points show the average of n≥3 replicates and 
































Figure 5.3 Skin permeability to molecules of different sizes: fluorescein (323 Da), 
calcein (623 Da), and fluorescein-tagged dextran (3,000 Da). Pretreatment 
solutions were without (■) and with (□) magainin. Data points show the average 
of n≥3 replicates and error bars correspond to the standard error of the mean.  
 
 
that a minimum pretreatment time of 6 h is required for significant enhancement. 
To better understand the mechanism behind these kinetics, we imaged skin after 
different pretreatment times using red-fluorescence labeled magainin and green-
fluorescent fluorescein. The resulting images, shown in Figure 5.1B, indicate that 
over time more magainin was able to penetrate into the stratum corneum (the upper 
10 – 15 µm of skin), which corresponded to more fluorescein transport across the 
stratum corneum and into the deeper skin.  
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    We next hypothesized that increased magainin concentration should increase skin 
permeability to fluorescein. As shown in Figure 5.2, increasing magainin 
concentration up to 1 mM increased skin permeability (ANOVA, p<0.05). However, 
further increasing magainin concentration to 2 mM decreased the enhancement ratio 
by more than a factor of two (Student’s t-test, p<0.01). This effect might be explained 
by aggregation of high-concentration magainin in the stratum corneum lipids, which 
may disrupt and occlude the expected pore structures formed by lower-concentration 
magainin  [147]. This explanation requires further study.     
    Finally, we hypothesized that skin permeability increased by magainin should be 
more effective for lower molecular weight molecules. Figure 5.3 shows skin 
permeability to molecules of three different sizes: fluorescein (323 Da), calcein (623 
Da), fluorescein-tagged dextran (3,000 Da). Skin permeability to fluorescein was 
significantly increased (Student’s t-test, p<0.01), but permeability to the two larger 
molecules was not significantly affected by magainin (Student’s t-test, p>0.05). This 
can be explained because magainin is believed to form Angstrom-scale pores across 
lipid bilayers that are known to be large enough for transport only of small 







5.4. Conclusion  
 
This study provided three main conclusions. First, we found that increased 
magainin pretreatment exposure time increased skin permeability to fluorescein by 
enabling more magainin to enter the stratum corneum. Second, increased magainin 
concentration up to 1 mM was shown to increase skin permeability to fluorescein, but 
2 mM fluorescein reduced this effect, perhaps due to magainin aggregation. Finally, 
skin permeability increased by magainin was effective for low molecular weight 
fluorescein (323 Da), but not for higher molecular weight calcein (623 Da) or dextran 
(3,000 Da). Overall, this study shows that magainin-based formulations can be 










CHAPTER 6: TRANSDERMAL DELIVERY ENHANCED 




Most animals and plants are constantly exposed to harmful pathogens. Innate 
defense systems such as gene-encoded antimicrobial peptides (AMPs) help fight off 
these pathogens and avoid infection [65,150]. More than 750 different antimicrobial 
peptides, either inducible or constitutive, have been identified and investigated in a 
wide range of eukaryotic organisms including humans [3].  Pathogenic organisms 
that are resistant to conventional antibiotics have emerged as a major medical 
problem; therefore, the pharmacological application of antimicrobial peptides has 
been considered as a potential novel therapeutic agent, because these peptides act via 
specific permeabilization of microbial membranes [1,4]. 
Transdermal delivery using chemical agents have been investigated for more 
than two decades [106]. However, biochemical molecules such as peptides have not 
been studied as skin permeation enhancers extensively. Most research has been based 
on using the conjugation of peptides with target molecules of interest to aid in 
delivery across biological barriers [73,74]. TD-1 peptide was developed for enhancing 
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delivery of insulin and achieved efficient delivery of cargo into the skin without 
linkage or direct conjugation with cargo, but the mechanism was assumed to be 
different from that of conventional percutaneous enhancers and appeared to involve 
transport through hair follicles [8]. Our previous work was the first to use a peptide as 
a percutaneous enhancer with a mechanism similar to a chemical enhancer (i.e. lipid 
disruption)  [146]. The exact mechanism has not been clearly elucidated yet, but the 
pore-forming peptide, magainin, demonstrated transdermal synergisitic enhancement 
of delivery. 
Numerous magainin peptide derivatives which were modified by changing 
charge, hydrophobicity, hydrophobic momentum, and helicity have been reported. For 
example, increasing the magainin charge to +5 resulted in a higher antimicrobial 
activity due to an increase of ionic peptide–membrane interaction [151,152]. 
Modifying α-helical structure of magainin by substituting helix promoting residues 
also increased antimicrobial activity [153]. Hydrophobic peptide-membrane 
interactions have an effect on hemolytic activity due to the affinity of the peptides to 
zwitterionic membranes [154,155].  
In this study, we hypothesize that a modification of magainin peptide will 
change the enhancing characteristics of magainin peptide. We would like to 
investigate which of these characteristics is critical for enhancement properties.  
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6.2. Materials and Methods 
 
6.2.1 Skin preparation 
  Same as Chapt 3. 
 
6.2.2 Skin permeability measurement  
 Same as Chapt 3. 
 
6.2.3 Modified magainin peptides synthesis 
All modified magainin peptides were synthesized by Shanghai GL 
Biochemicals with standard solid-phase FMOC method with an automatic peptide 
synthesizer (CS Bio). The sequences and characterisitics of magainin-modified 
peptides are shown in Table 1.  
 
6.2.4 Circular dichroism spectra 
Circular dichroism spectra were acquired on a JASCO J-720 CD 
spectropolarimeter (JASCO, Easton, MD). The spectrum of each sample was obtained 
by scanning using a capped quartz optical cell (1 mm path length cell; Starna cells, 
Atascadero, CA, USA) at room temperature, at a wavelength of 250 to 195 nm with 
continuous scanning mode. Samples were scanned five times at a scan rate of 500 
nm/min and a peptide concentration of 5
10-5 M in 50% ethanol-PBS solution. 
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6.2.5 Fourier transform infrared spectroscopy (FT-IR) 
Same as Chapt 3. 
 
6.2.6 Statistical Analysis 
 Skin permeability to fluorescein and FTIR spectroscopy were measured using 
at least three replicate skin samples at each condition, from which the mean and 
standard error of the mean were calculated. A two-tailed Student’s t-test was 
performed when comparing two different conditions. When comparing three or more 
conditions, a one-way analysis of variance (ANOVA) was performed.  
 
6.3. Results and discussion 
 
6.3.1 Effect of magainin-modified peptides on skin permeability 
     To test our hypothesis that modification of magain peptide will affect skin 
permeation ability, we applied five different classes of modified magainin peptides for 
skin permeation enhancer in NLS-ethanol solution. Each modified peptide has a 
unique characteristic such as charge, hydrophobicity, and hemolytic activity. (Table 
6.1)  
     We first ran a control experiment using a solution containing only NLS 
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Table 6. 1 Various magainin derivitives 
 
  Modification Characterisitic Sequences 
B Magainin  [68] - Antimicrobial activity GIGKFLHSAKKFGKAFVGEIMNS 
C Anti-magainin 
Charge of magainin 
modified to negative 
Unknown GIGEFLHSAEEFGEAFVGEIMNS 




E Magainin H [153] 
Replace L-Ala with D-Ala 
from magainin F 
No antimicrobial & 
hemolytic activity 
GIGKFLHSaKKFaKAFVaEIMNS 
F Magainin F [153] 














surfactant and no peptide. Consistent with previous findings [146], this formulation 
caused a 16 fold increase in skin permeability. (Figure 6.1 Sample A) Also consistent 
with our previous work [146], the addition of magainin peptide increased skin 
permeability 33 fold, (Figure 6.1. Sample B) which was almost twice greater than 
NLS alone. (Student’s t test, p<0.05) 
To asses the role of charge, we modified two different charged peptides.  
First, in order to make negative charged-magainin, we replaced all of the 
positively charged amino acids in magainin (Lysine) with a negatively charged amino 
acid (Glutamic acid) to form “anti-magainin”. This modified peptide (Figure 6.1. 
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Sample C) had no significant effect on skin permeability and an even lower 
enhancement ratio than NLS-alone control (Student’s t test, p<0.05).  
     Second, in order to increase the charge of magainin from +4 to +5, we replaced 
several amino acids. This high positive charged-magainin peptide (Figure 6.1. Sample 
D) increased skin permeability 20 fold, but was not statistically different from NLS 




























Figure 6. 1 Transdermal fluorescein skin permeability enhancement ratio of skin 
samples treated with NLS and (A) no peptide, (B) with magainin, (C) with anti 









 relative to untreated skin. Data represent averages of n≥3 samples 
with standard error of the mean. The * symbol identifies skin samples with 
enhancement statistically higher than the enhancement by NLS alone (Student’s 
t-test, p<0.05). 
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We also tested a modified peptide which has no antimicrobial and hemolytic 
activity at all (Figure 6.1. Sample E). This peptide did not show any enhancement 
effect (Student’s t test, p>0.5).  
Replacing Gly with Ala to increase helix formation (Figure 6.1. Sample F) 
demonstrated increased skin permeability by 24 fold and it was a statistically 
significant enhancement (Student’s t test, p<0.05). However, it was not better than 
enhancement by original magainin peptide.  
Finally, in order to test the effect of hydrophobicity (Figure 6.1. Sample G), we 
increased hydrophobicity by substitution of four amino acids. This modified peptide 
resulted in no enhancement and rather showed an adverse effect (Student’s t test, 
p<0.05).  
Therefore, we could not find any correlation between antimicrobial activity and 
the change in skin permeability. 
 
6.3.2 Fourier transform infrared spectroscopy 
Fourier transform infrared spectroscopy was used to investigate the stratum 
corneum lipid structural change caused by modification of magainin peptides.  
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Figure 6. 2 Fourier-transform infrared spectroscopy analysis of human stratum 
corneum treated with different formulations. (A) Spectra of wavenumbers 
characteristic of C-H stretching in lipids treated with (from bottom to top): PBS, 
NLS, magainin, anti magainin, magainin 5KE, magainin H, magainin F, 
magainin I6A8 with NLS in aqueous 50% ethanol Dashed lines indicated peaks 
of interest. Graphs are representative of n≥3 replicate samples. (B) Change of (1) 
CH2 asymmetric stretching frequency, (2) CH2 symmetric stretching frequency. 
Data represent averages of n≥3 samples with standard error of the mean. The * 
symbol identifies wavenumbers significantly greater than skin treated with just 



















 Representative IR absorbance spectra from 2970-2820 cm-1 of human stratum 
corneum samples treated with various formulations are displayed in Figure 6.2A. The 
wave-number position of the characteristic spectral peaks is shown in Figure 6.2B. As 
shown in Figure 6.2B, there is a significant difference between control sample treated 
with PBS and those samples treated with NLS or NLS with modified magainin 
peptides (ANOVA, p[νas(CH2)] <0.01, p[νs(CH2)] <0.01). The increased wave-
numbers of the two C-H stretching peaks by samples treated with NLS-modified 
magainin peptides are statistically higher than those treated by NLS alone (Student’s t 
test, p[νas(CH2)] <0.05, p[νs(CH2)] <0.05). However, this does not hold for the sample 
treated with anti-magainin.  
From this result, we observed that magainin and magainin derivatives (except 
for antimagainin) with NLS fluidized stratum corneum lipid further than NLS alone, 
however, fluidization is not the only cause of skin permeability increase. When we 
compare Figure 6.1 and 6.2, the wave number increase of CH-stretching of the skin 
treated with magainin-NLS is similar to that of the skin treated by NLS with magainin 
MK5E,  magainin F, magainin I6A8L15I17, and magainin H; however, transdermal 
penetration enhancement was achieved by original magainin and magainin F only. 
Though the mechanism of transdermal penetration enhancement by magainin-NLS 
has not been clearly elucidated yet, the skin permeability enhancement may not result  
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Figure 6. 3 Circular dichroism spectra of various modified magainins in 50% 
ethanol 
 
merely from skin lipid fluidization. As mentioned in the previous chapter, ionic 
interactions between peptide and delivered molecules could cause a significant effect. 
 
6.3.3 Circular dichroism (CD) spectra  
In order to identify differences between the magainin derivatives that could 
explain their different behaviors, we used CD spectroscopy. As shown in Figure 6.3, 
even though alpha helicity is different, all modified magainin peptide maintained 
alpha helical structure in a hydrophobic environment. Therefore, alpha helical 
structure may be necessary for skin permeability enhancement, but it is not significant 
and therefore does not provide an explanation for the different behaviors of the 
magainin deravitives. 












This study showed that the modification of magainin by sequence replacement 
has a significant influence on the transdermal enhancement characterisitics of the 
peptide. By investigating the structure and fluidization ability of each modified 
magainin peptide, we have concluded that alpha helicity and lipid fluidization ability 
are not distinguishing factors for percutaneous enhancement. This suggests that lipid 













CHAPTER 7: TRANSDERMAL DELIVERY ENHANCED 
BY MAGAININ PEPTIDE - MODIFICATION OF 




 Traditional approaches to increase transdermal drug delivery  [156] have 
involved synthetic chemical enhancers, such as surfactants, fatty acids, and 
solvents  [106], and physical enhancers, such as electric fields, ultrasound, heat, and 
microneedles  [157]. Recent work has considered the use of biochemical enhancers, 
such as an 11-amino acid synthetic peptide identified by phage display 
screening  [76], a polyarginine heptamer covaltently bonded to a drug using a prodrug 
approach  [74], and a naturally occurring pore-forming peptide called 
magainin  [146], which is the subject of this study.  
  Magainin is a 23-residue peptide that is naturally produced on the skin of 
African clawed frogs and exhibits a broad spectrum of antimicrobial activity 
properties  [68]. It has a net charge up to +4 and binds to negatively charged lipid 
membranes by way of electrostatic interactions. It is believed to be a random coil in 
aqueous solution that forms an amphipathic helix when adsorbed onto a negatively 
charged membrane such as the surface of a bacterium. Magainins can then self-
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assemble into transmembrane pores that make the cell membrane leaky and can also 
lead to cell lysis.  
     We previously hypothesized that magainin could be used to make lipid bilayers 
in the skin’s stratum corneum leaky as well, and showed that magainin can increase 
skin permeability when delivered from a formulation including an anionic surfactant, 
N-lauroyl sarcosine,in a 50% ethanol-PBS solution  [146]. Initial tests showed that 
magainin alone had no effect on skin permeability, probably because the relatively 
large magainin molecule had difficulty penetrating throughout the stratum corneum to 
make continuous transdermal pathways. Addition of the anionic surfactant increased 
skin permeability and thereby facilitated magainin penetration throughout the stratum 
corneum, which provided a synergistic enhancement. This enhancement was 
accompanied by increased stratum corneum lipid fluidity, as shown through 
differential scanning calorimetry, infrared spectroscopy and X-ray diffraction 
measurements. These results were consistent with the hypothesis that magainin makes 
stratum corneum lipid layers leaky.  
 Building off these observations that magainin, in the presence of surfactant, 
interacts with stratum corneum to increase permeability, this study seeks to 
investigate the role of interactions between magainin and the drug as it diffuses 
through magainin-mediated pathways in the stratum corneum. We expect that the 
charge properties of magainin play a role in these interactions, especially with 
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charged drugs, and have therefore investigated this effect by changing the magainin 
charge state by changing pH. We hypothesize that electrostatic forces between 
magainin peptides and drugs mediate drug transport across the skin. 
  Previous studies have shown that changing pH can alter the structure and 
properties of antimicrobial peptides in various ways, such as switching between the 
nematic and isotropic phase of a β-sheet peptide  [158], changing the charge of a 
transmembrane α-helical peptide  [159], enhancing antimicrobial activity  [160], 
controlling haemolytic activity  [161], and altering pore-formation properties  [162].  
     The effect of pH on transdermal delivery has also been investigated, but has 
primarily focused on the effects of pH changes on drug properties, such as solubility. 
For example, indomethacin delivery was enhanced under acidic conditions due to 
increased drug stability  [163] and the dependence of skin permeability to cephalexin 
on pH was described by a U-shaped curve  [164].  
 
7.2. Materials and methods 
 
7.2.1 Skin preparation 
Same as Chapt 3. 
 
7.2.2 Skin permeability measurement  
    Skin permeability measurements were carried out in three steps. As a first step, 
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skin pretreatment was performed using epidermis (0.7 cm2 skin surface area) mounted 
in a vertical, glass Franz diffusion cell (PermeGear, Bethlehem, PA, USA). A solution 
of 1 mM magainin peptide (Microchemical and Proteomics Facility, Emory 
University School of Medicine) and 2% (w/v) N-lauroylsarcosine (NLS, 98%, Fluka, 
Buchs, Switzerland) in 50% (v/v) aqueous ethanol solution was placed in the donor 
chamber and phosphate-buffered saline (PBS, Sigma Aldrich, St. Louis, MO, USA) 
was placed in the receiver chamber for 12 h at 4 oC to minimize skin degradation. The 
magainin solution had a pH of 3.5 and the PBS had a pH of 7.4.  
As a second step, the Franz cell was removed from refrigeration and placed in a 
heater/stirrer block (PermeGear) that warmed the receiver chamber at 37 oC and 
maintained stirring at 455 rpm. 
As a third step, fresh PBS (pH from 5 to 12) was placed in the receiver chamber 
and 0.3 mL of 1 mM fluorescein (Sigma Aldrich, St. Louis, MO, USA) solution in 
PBS (pH from 7.4 to 12) or 1 wt% granisetron hydrochloride (Ultratech SPC PVT 
Ltd., Mumbai, India) solution in PBS (pH from 5 to 10) was placed in the donor 
chamber, which replaced the magainin/NLS solution. Every hour for 5 h, the receiver 
solution was removed for sampling and then replaced with fresh PBS (pH from 5 to 
12). The pH of sample solution was adjusted to pH 7.4 by adding 1 N nitric acid to 
decrease pH and 1 N NaOH solution to increase pH. Samples containing fluorescein 
were analyzed by spectrofluorimetry (Photon Technologies International, 
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Birmingham, NJ, USA) to determine fluorescein concentration, from which 
transdermal fluorescein flux was calculated. Samples containing granisetron were 
analyzed by HPLC, as described below.  
 
7.2.3 HPLC analysis 
HPLC analysis was carried out using an Alliance HPLC system (Waters, 
Milford, MA, USA) with Empower software, a fluorescence detector (Waters 2475, 
305 nm excitation, 350 nm emission gain setting of 1) and a Spherisorb Cyano 
column (4.6 × 250 mm, Waters). Samples were injected directly into the column and 
eluted in a 72:28 mixture of acetate buffer (25 mM) and acetonitrile at a flow rate of 1 
mL/min. Calibration curves were prepared at a concentration range of 10 – 100 ng/mL 
granisetron. 
 
7.2.4 Multi-photon excitation microscopy 
    To image magainin and fluorescein distribution within the skin, epidermis was 
treated as described above for skin permeability experiments, except that 
sulphorhodamine-tagged magainin (Microchemical and Proteomics Facility, Emory 
University School of Medicine) was used instead of the un-labeled magainin used in 
the first step and the experiment was terminated after 3 h exposure to fluorescein in 
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the third step, after which the skin sample was removed from the Franz cell and 
placed on a glass cover-slip. 
  Imaging was carried out using a Zeiss LSM/NLO 510 Confocal/Multi-Photon 
Microscope (Zeiss, Oberkochen, Germany) with a 40× oil-immersion objective used 
in conjunction with an oil having an index of refraction of 1.51, which is similar to 
that of the stratum corneum  [165,166].  
 
7.2.5 Circular dichroism spectra 
Solutions were prepared containing 50 µM magainin in 50% ethanol. pH was 
adjusted to a value between 7.4 and 12. Solutions were placed in a capped quartz 
optical cell (1 mm path length; Starna cells, Atascadero, CA, USA) and circular 
dichroism spectra were acquired on a JASCO J-720 CD spectropolarimeter (JASCO, 
Easton, MD). Spectra were obtained at room temperature by scanning five times from 
250 nm to 200 nm at a rate of 500 nm/min in continuous scanning mode.  
 
7.2.6 Fourier transform infrared spectroscopy 
 Stratum corneum was exposed to magainin-NLS solution for 15 h at 4 oC. Then 
stratum corneum samples were transferred to different pH buffer solutions for 5 h and 
washed with PBS solution. Fourier-transform infrared spectra were then obtained 
using a Magma-IR 560 FTIR spectrometer (Nicolet, Thermo Electron Corporation, 
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Waltham, MA, USA). Reported spectra represent the average of 64 scans over the 
frequency range of 4000 - 1000 cm-1. OMNIC professional software (Thermo 
Electron Corporation) was used to measure the peak position. Although the FTIR had 
a data collection spacing of 4 cm-1, interpolation between points is reliable because 
the noise level is so low and the reproducibility of FTIR spectra is so high. This 
permits one to determine the location of a peak, even if it exists between data points 
that were actually collected. This is well established in the spectroscopy 
literature  [167] and is consistent with many previous studies involving FTIR analysis 
of skin, where peak shifts much smaller than the data collection spacing are 
reported  [39,125]. 
 
7.2.7 Statistical Analysis 
     Transdermal penetration of fluorescein and granisetron and FTIR spectra were 
measured using at least three skin specimens, from which the mean and standard error 
of the mean were calculated. A two-tailed Student’s t-test (α=0.05) was performed 
when comparing two different conditions. When comparing three or more conditions, 
a one-way analysis of variance (ANOVA; α=0.05) was performed. In all cases, a 




7.3. Results and discussion 
  
7.3.1 Effect of pH on transdermal flux of fluorescein 
 We hypothesize that electrostatic forces between magainin peptides and drugs 
mediate drug transport across the skin. To address this issue, we measured skin 
permeability to fluorescein over a pH range of 7.4 to 12. Over this range, the charge 
of the skin  [168], NLS surfactant, and fluorescein should all remain strongly 
negative. However, magainin has an isoelectric point at pH 10.5, such that magainin 
changes from a +2 positive charge at pH 7.4 to a neutral charge at pH 10.5 and a 
negative charge at pH 12 [169]. Electrostatic forces between magainin and drugs 
mediate drug transport across the skin. 
 We first carried out a control experiment to assess the effect of pH on skin 
permeability to fluorescein after pretreatment with NLS (without magainin). At pH 
7.4, skin permeability was increased 16 fold by the NLS control formulation, as 
shown in Figure 7.1. Increasing to pH 11 had no additional effect (ANOVA, p = 0.73), 
which is consistent with the expectation that the charge of skin, NLS and fluorescein 
should be unaffected by increased pH. However, at pH 12, skin permeability 
approximately doubled relative to pH 7.4 (Student’s t-test, p < 0.05). This suggested a 







































Figure 7. 1 Enhancement of transdermal fluorescein delivery as a function of pH. 
Skin was pre-treated with NLS () or magainin + NLS () in 50% ethanol. 
Enhancement ratio represents the increase in transdermal fluorescein 
transported across skin over 6 h  at various pH values compared to delivery 
under identical conditions using a formulation of fluorescein in PBS. The * 
symbol identifies enhancement ratios for magainin + NLS that are significantly 
different from NLS at the same pH (Student’s t-test, p < 0.05). The † symbol 
identifies enhancement ratios at a given pH that are significantly different from 
the same formulation at pH 7.4 (Student’s t-test, p < 0.05). Data represent 
averages of n ≥ 3 samples ± standard error of the mean.   
 
 
previous observations that skin permeability is not generally changed at pH values up 
to 11 [170], but exposure to pH 12 can increase skin permeability  [170]. 
 Skin permeability to fluorescein after treatment with magainin and NLS was 
increased by a factor of 35 at pH 7.4, as shown in Fig. 1. This increase is significantly 
larger than for NLS without magainin (Student’s t-test, p < 0.01). However, raising 
the pH, and thereby reducing magainin charge, progressively removed magainin’s 
enhancement until pH 11 (ANOVA, p < 0.05). This suggests that a positively charged 
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magainin facilitated transdermal transport of negatively charged fluorescein due to 
electrostatic attraction at pH 7.4, but as the attraction decreased with increasing pH, 
the skin permeability enhancement decreased as well. 
 At pH 12, skin permeability was again increased to a 106-fold enhancement, as 
shown in Fig. 1 (Student’s t-test, p < 0.01). Although at this pH magainin is 
negatively charged, which should repel the negatively charged fluorescein, the control 
experiment suggested that skin itself was altered by the high pH, which complicates 
any mechanistic interpretation. 
 
7.3.2 Effect of pH on transdermal flux of granisetron 
 
The effect of pH on skin permeability might be mediated by changes in the 
electrostatic interactions between magainin and fluorescein, but might also be 
mediated by changes in the interactions between magainin and skin. To address this 
uncertainty, we measured the effect of pH on skin permeability to granisetron, which 
differs from fluorescein in that it carries a positive charge, but is similar in that its 
molecular weight (349 Da) is similar to fluorescein (332 Da).  
The control formulation of NLS without magainin at pH 7.4 enhanced transdermal 
granisetron delivery 59 fold, as shown in Figure 7.2. Neither decreasing to pH 5 nor 
increasing to pH 10 had any additional effect (ANOVA, p = 0.84). Unfortunately, we 
could not test pH 11 or 12 due to precipitation of granisetron at high pH. 
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Unlike for fluorescein, the addition of magainin at pH 7.4 had no additional 
effect on skin permeability to granisetron (Student’s t-test, p = 0.167), as shown in 
Figure 7.2, perhaps because of repulsion between the positively charged magainin and 
positively charged granisetron. Decreasing the pH to 5, which increased magainin 
charge to a value of +4, resulted in a reduction of granisetron delivery (Student’s t-







































Figure 7. 2 Enhancement of transdermal granisetron delivery as a function of pH. 
Skin was pre-treated with NLS () or magainin + NLS () in 50% ethanol. 
Enhancement ratio represents the increase in transdermal granisetron 
transported across skin over 6 h at various pH values compared to delivery 
under identical conditions using a formulation of granisetron in PBS. The * 
symbol identifies enhancement ratios for magainin + NLS that are significantly 
different from NLS at the same pH (Student’s t-test, p < 0.05). The † symbol 
identifies enhancement ratios at a given pH that are significantly different from 
the same formulation at pH 7.4 (Student’s t-test, p < 0.05). Data represent 
averages of n ≥ 3 samples ± standard error of the mean.   
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and raising the pH to 10, which almost eliminated magainin charge, increased 
granisetron delivery to a peak value of 92–fold enhancement (Student’s t-test, p 
<0.05) due to removal of the electrostatic repulsion. 
The opposite effects of pH on skin permeability to fluorescein versus granisetron 
suggest that the pH changes influenced interactions between magainin and each 






































Figure 7. 3 Enhancement of transdermal fluorescein delivery as a function of 
NaCl concentration. Skin was pre-treated with NLS () or magainin + NLS () 
in 50% ethanol at pH 7.4. Enhancement ratio represents the increase in 
transdermal fluorescein transported across skin over 6 h at various salt 
concentrations compared to delivery under identical conditions using a 
formulation of fluorescein in PBS. The * symbol identifies enhancement ratios 
for magainin + NLS that are significantly different from NLS at the same salt 
concentration (Student’s t-test, p < 0.05). The † symbol identifies enhancement 
ratios at a given pH that are significantly different from the same formulation at 
0 M NaCl (Student’s t-test, p < 0.05). Data represent averages of n ≥ 3 samples ± 
standard error of the mean.   
 135 
7.3.3 Effect of salt concentration on transdermal flux of fluorescein 
To further test whether the effect of pH on skin permeability is mediated by 
electrostatic interactions between magainin and the model drug, we changed salt 
concentration rather than changing pH to alter electrostatic interactions. An increase 
of salt concentration screens out electrostatic effects between charged species  [171]. 
Thus, increased salt concentration should effectively neutralize charge-charge 
interactions in a way similar to increasing pH to the magainin isoelectric point.  
For the NLS control formulation, skin permeability to fluorescein was unaffected 
by salt concentration, as shown in Figure 7.3 (ANOVA, p = 0.51). This is consistent 
with the expectation that skin permeability enhancement by NLS is not mediated by 
electrostatic interactions. For skin treated with NLS and magainin peptide, skin 
permeability was increased by magainin at salt concentrations of 0 M and 0.5 M 
(Student’s t test, p <0.01). However, increasing the salt concentration to 1 M or 2 M 
eliminated magainin’s enhancement effect, such that skin permeability was 
indistinguishable from the NLS control (Student’s t test, p >0.05). This result further 
confirms the interpretation that magainin increases transdermal transport when there 
is an attractive electrostatic interaction with a drug and loses its ability to enhance 




7.3.4 Circular dichroism analysis of magainin structure  
Changing the pH could alter magainin structure, which could additionally affect 
skin permeability enhancement. To assess the effects of pH on magainin secondary 
structure, we collected circular dichroism spectra of magainin solutions over a range 
of pH from 7.4 to 12. These spectra showed that magainin retained a α–helix structure 
over the pH range studied, as shown in Figure 7.4. Although this experiment was 
done using magainin in solution, rather than within the skin, these results suggest that 
magainin structure was not altered by pH.  
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Figure 7. 4 Circular dichroism spectra of magainin as a function of pH. 














7.3.5 Microscopy analysis of magainin and fluorescein delivery into stratum corneum 
 Changing pH could alter the amount of magainin in the stratum corneum, which 
could thereby alter skin permeability. To assess the effects of pH on magainin content 
in the stratum corneum, we imaged the amount of sulforhodamine-labelled magainin 
inside stratum corneum using multi-photon excitation microscopy at various pH 
values. Magainin delivered to skin in the absence of NLS surfactant had limited 
penetration into the skin and showed no dependence on pH, as shown in Figures 7.5A 
– 5D. Magainin formulated with NLS was delivered to a much greater extent than in 
the absence of NLS, but also did not show any dependence on pH, as shown in 
Figures 7.5E – 5H. These data indicate that the effects of pH on skin permeability 
cannot be explained by changes in the amount of magainin peptide present in the 
stratum corneum. 
      To provide additional insight into the flux data presented in Figure 7.1, we 
imaged the amount of fluorescein delivered into the skin using multi-photon 
excitation microscopy at various pH values. Consistent with the flux data, optical 
sections through the epidermis show that the smallest amount of fluorescein was seen 
in the skin at pH 10, when magainin charge was almost neutralized (Figure 7.6B); a 
greater amount was seen at pH 7.4, when magainin carried a +2 charge that attracted 
negatively charged fluorescein (Figure 7.6A); and the greatest amount was seen at pH 
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Figure 7. 5 Penetration of sulforhodamine-tagged magainin peptide into human 
epidermis imaged by multi-photon microscopy. Skin was pre-treated with 
magainin formulated (A-D) without NLS and (E-H) with NLS for 15 h. Skin was 
exposed PBS solution for 5 h at pH (A, E) 5, (B, F) 7.4, (C, G) 10, and (D, H) 12. 
Optical sections were taken at 5 µm increments starting at the stratum corneum 




















Figure 7. 6  Penetration of fluorescein into human epidermis imaged by multi-
photon microscopy. Skin was treated with magainin + NLS. Fluorescein was 
delivered to skin for 5 h at (A, D) pH 7.4, (B, E) pH 10, and (C, F) pH 12. (A-C) 
Optical sections were taken at 5 µm increments starting at the stratum corneum 
surface on the left and proceeding deeper on the right. Scale bar is 100 µm. (D-F) 
Cross-sectional images were reconstructed as z-stacks with the stratum corneum 










showing cross-sectional views of the epidermis in Figures 7.6D – 6F provide similar, 
complimentary results. Transdermal transport was not imaged at lower pH values (e.g., 
pH 5) due to extensive fluorescein bleaching at acidic pH  [172]. 
 
 
7.3.6 Fourier transform infrared spectroscopy 
Changing pH could directly alter stratum corneum lipid structure or could 
change the way that magainin alters stratum corneum lipid structure. To assess these 
effects, we used Fourier-transform infrared spectroscopy to measure the degree of 
stratum corneum lipid disruption. Representative spectra are shown for untreated skin 
(Figure 7.7A), skin treated with NLS (Figure 7.7B) and skin treated with magainin 
and NLS (Figure 7.7C) as a function of pH. Characteristic peaks can be seen in these 
spectra near 2920 cm-1, which corresponds to asymmetric C-H stretching, and near 
2850 cm-1, which corresponds to symmetric C-H stretching. The frequencies of these 
C-H stretching bands are related to lipid order in stratum corneum and are 
significantly influenced by the degree of conformational order, the freedom of alkyl 
chain motion, and possible incorporation of chemical enhancers, such as NLS  [97]. 
 To address the effect of pH alone on skin, the frequency of the two 
characteristic peaks showed no dependence on pH (ANOVA; Figure 7.7D, black 
circles, p = 0.26; Figure 7.7E, black circles, p = 0.89). This indicates that pH itself did 
not affect stratum corneum lipid order. Thus, the increased skin permeability 
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observed at pH 12 in Figure 7.1 cannot be explained by increased lipid disorder. This 
finding is consistent with a previous study which reported that exposure to pH 12 for 
24 h did not shift the position of these characteristic peaks  [173]. 
After treatment with formulations containing NLS or magainin + NLS, there 
was no statistically significant effect on lipid order over the pH range of 7.4 to 12 for 
skin treated with NLS (ANOVA; Figure 7.7D, gray squares, p = 0.54; Figure 7.7E, 
gray squares, p = 0.12) and with magainin + NLS (ANOVA; Figure 7.7D, white 
triangles. p = 0.29; Figure 7.7E, white triangles, p = 0.09). However, exposure at pH 5 
significantly decreased the peak frequency (i.e., increased lipid order) for skin treated 
with NLS (ANOVA; Figure 7.7D, gray squares, p < 0.01; Figure 7.7E, gray squares, p 
< 0.01) and with magainin + NLS (ANOVA; Figure 7.7D, white triangles, p < 0.05; 
Figure 7.7E, white triangles, p < 0.05), when considered over the full range of pH 5 to 
12.  
     Although the lowest pH had an effect of lipid order, there was no effect over the 
pH range of 7.4 to 12, which is the range over which pH was shown to have a 
dramatic effect on skin permeability to fluorescein in Figure 7.1. These data suggest 
that the effects of pH on skin permeability cannot be explained by changes in stratum 










Figure 7. 7 Fourier-transform infrared spectroscopy analysis of human stratum 
corneum treated with different formulations as a function of pH. Representative 
spectra highlighting wavenumbers characteristic of C-H stretching in stratum 
corneum lipids after pre-treatment with (A) PBS, (B) NLS, and (C) magainin + 
NLS for 15 H and soaked in PBS at pH 5, 7.4, 10 and 12 (shown from top to 
bottom). Dashed lines identify peaks of interest. Change of (D) CH2 asymmetric 
stretching frequency and (E) CH2 symmetric stretching frequency for stratum 
corneum pre-treated with PBS (●), NLS (■), and magainin + NLS (∆) 
determined from graphs like (A), (B) and (C), respectively. Data represent 
averages of n ≥ 3 samples ± standard error of the mean. The * symbol identifies 
wavenumbers significantly different from the corresponding wavenumber at pH 






















































Figure 7.7. Continued 
 
 
7.3.7 Interpretation of the data 
Our previous studies showed that NLS surfactant is needed to drive magainin into 















penetration into the stratum corneum in the absence of NLS and extensive magainin 
penetration with NLS. Our previous studies also showed that the presence of 
magainin increased skin permeability, which is consistent with Figures 7. 1 and 2, and 
the increased skin permeability was associated with increased stratum corneum lipid 
disorder, which is consistent with Figure 7.7.  
For the first time, this study examined the effects of pH on skin permeability and 
other properties. Our data support the hypothesis that electrostatic forces between 
magainin peptides and drugs mediate drug transport across the skin. We found that 
transdermal transport of negatively charged fluorescein decreased as the positive 
charge of magainin was reduced by increasing pH. We also found that transdermal 
transport of positively charge granisetron increased as the positive charge of magainin 
was reduced by increasing pH. Finally, we found that transdermal transport of 
fluorescein also decreased as the screening of electrostatic interactions with magainin 
increased by increasing salt concentration.  
These three observations are all consistent with the proposed hypothesis and are 
not consistent with changes in magainin conformation, magainin content in the skin or 
magainin interaction with the skin being directly responsible for increased 
transdermal transport. This is because these effects should not depend on the charge 
of the molecule being delivered across the skin and should not be effected by 
changing the pH and by increasing salt concentration. 
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  In addition, CD measurements demonstrated that pH did not change the 
secondary structure of magainin in ethanol solution, microscopy indicated that pH did 
not affect the magainin content in the stratum corneum, and FTIR showed that pH did 
not affect lipid order, except at the lowest pH. Altogether, these data suggest that 
electrostatic interactions between magainin peptides and drugs provide the most 
plausible explanation for the observed effects.  
 
7.3.8 Debye length calculations 
 The effect of salt concentration on skin permeability provides an opportunity to 
further evaluate the transport pathways created by magainin peptides. As salt 
concentration increases, the Debye length decreases. The Debye length is a measure 
of the distance over which the electric field of a charge is felt. As greater numbers of 
salt ions in solution surround the charge on a magainin peptide, they shield its electric 
field. 
  Debye length, λD, can be calculated at the conditions used in this study  [174]. 







λ =                                  (1) 
where ε0 is the permittivity of an electrical field in free space (8.8542 x 10
-12 F m-1), εr 
is the dielectric constant (66.89 for 0.5 M saline and 59.89 for 1.0 M saline at 32ºC 
and 1 atm  [175-177], R is the gas constant (8.314 N m K-1 mol-1), T is the absolute 
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temperature (310.15 K), F is the Faraday constant (96,485.34 C mol-1), and C is the 
salt concentration (0.5 M or 1.0 M).  
 At a salt concentration of 0.5 M, the Debye length is 4.02 Å. At this salt 
concentration, the electrostatic interactions between magainin peptides and 
fluorescein molecules were still effective. At a salt concentration of 1 M, the Debye 
length is 2.69 Å. At this salt concentration, the electrostatic interactions between 
magainin peptides and fluorescein molecules were blocked.  
 Fluorescein molecules have a radius of approximately 5 Å  [178]. The fact that 
the Debye length at which magainin – fluorescein interactions are shielded is smaller 
than the radius of the fluorescein molecule indicates that the pathways created by 
magainins in the skin are just slightly larger than a fluorescein molecule. The 
screening of the attractive electrostatic interaction by such a small change in the 
Debye length implies that the fluorescein molecule must be close to the edge of this 
pathway. This is consistent with our previous finding that magainin did not enhance 
transdermal transport of molecules larger than fluorescein  [179], such as calcein (623 
Da, r = 6 Å  [180] and dextran (3,000 Da, r = 16 Å  [181]. This is also consistent with 
previous studies of magainin in simpler lipid bilayer systems, in which the pores are 
believed to be of Angstrom dimensions  [148,149].   
 
7.3.9 Implications for drug delivery 
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 Biochemical enhancers are a novel approach to increasing skin permeability for 
transdermal drug delivery. However, the use of peptides to increase transdermal 
transport has been addressed in just a small number of studies. This study provides 
insight into the mechanism by which magainin peptides increases skin permeability, 
which may have broader relevance to other peptide-based enhancement strategies. 
 The use of magainin peptide in combination with NLS surfactant increased 
transdermal transport of fluorescein 35 fold at pH 7.4 and up to 106 fold at pH 12. 
Magainin with NLS also increased transdermal transport of granisetron 59 fold at pH 
7.4 and up to 92 fold at pH 10. These large increases in skin permeability may be 
useful for transdermal drug delivery. Although fluorescein is a model compound, 
granistron is a drug in clinical use to prevent nausea and is in late-stage development 
as a transdermal patch (ProStrakan announces filing of MAA for Sancuso, ProStrakan 
Group plc, Galashiels, Scotland, July 16, 2007).   
 The dependence of transdermal transport on pH, as well as on salt concentration, 
presents the opportunity to modulate or trigger transdermal delivery rates by 
increasing or decreasing pH or salt. Although we do not yet know the speed with 
which changing pH or salt concentration can alter transdermal transport, novel 
approaches to initiate, terminate or otherwise modulate transdermal delivery rates 





This study supported the hypothesis that electrostatic forces between magainin 
peptides and drugs mediate drug transport across the skin. Mechanisms of transport 
were studied by measuring rates of transdermal transport, fluorescence microscopy, 
and CD and FTIR spectroscopy,  
 Transdermal delivery of negatively charged fluorescein was shown to be increased 
35 fold using a formulation containing magainin peptide that carried a +2 charge at 
pH 7.4 and thereby provided an attractive electrostatic interaction with fluorescein. 
Increasing pH to 10 or 11, which neutralized the charge on magainin and thereby 
removed the electrostatic attraction, eliminated the enhancement due to magainin. 
Blocking electrostatic interactions at high salt concentration similarly eliminated the 
enhancement due to magainin. Finally, increasing pH to 12 increased transdermal 
fluorescein delivery 106 fold by a mechanism that appeared to involve effects of the 
pH on both the skin and magainin.  
Transdermal delivery of positively granisetron was shown to be increased 92 fold 
using the same formulation containing magainin peptide that was neutralized at pH 10. 
Decreasing pH to 7.4, which gave magainin a +2 charge and thereby provided a 
repulsive electrostatic interaction with granisetron, eliminated the enhancement due to 
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magainin. Decreasing pH further to 5, which gave magainin a +4 charge, inhibited 
granisetron flux. 
These observations are consistent with the stated hypothesis and are not consistent 
with changes in magainin conformation, magainin content in the skin, or magainin 
interaction with the skin being directly responsible for increased transdermal transport. 
CD analysis, fluorescence microscopy and FTIR spectroscopy, respectively, provided 
further evidence to rule out these alternative mechanisms.  
Overall, magainin peptides represent a novel class of biochemical enhancers of 
transdermal transport. Their ability to increase skin permeability and to be modulated 










CHAPTER 8: CONCLUSIONS 
 
  In order to deliver drugs across the skin efficiently, various percutaneous 
enhancers have been investigated. However, few enhancers can deliver drugs at 
therapeutic dosages while avoiding skin irritation or damage.  
    In this study, we found that an anionic surfactant – NLS - and ethanol solvent 
showed synergistic skin permeability enhancement. NLS penetrated into the skin lipid 
domain with the aid of ethanol, whereupon NLS could fluidize the lipid domain of the 
stratum corneum. When magainin was applied with the NLS-ethanol formulation, 
additional synergy was found. After NLS and ethanol disrupted the skin, the magainin 
peptide was able to penetrate into the stratum corneum. Although, the skin was more 
fluidized by the addition of the magainin peptide, flux increased by an amount 
disproportionately higher than the fluidization increase. Modified magainin 
derivitives were able to fluidize the stratum corneum lipid, but they did not 
demonstrate skin permeability enhancement to fluoresceinn. We found that skin 
permeability enhancement is not solely caused by skin lipid disruption. The 
enhancement appears to result from a charge interaction between the magainin 
peptide and the transporting molecule. 
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    The first part of this thesis investigated the mechanism of transdermal drug 
delivery enhancement using mixtures of NLS and ethanol. Skin permeability to 
fluorescein depended strongly on NLS concentration. The ethanol concentration also 
strongly affected skin permeability, where formulations containing NLS in 25% and 
50% ethanol dramatically enhanced transdermal delivery. Increased skin permeability 
strongly correlated with the skin’s electrical resistance, decreased lipid transition 
temperatures by DSC, and increased wavenumber of CH stretching by FTIR, which 
indicated increased fluidity of the stratum corneum. The synergistic effect of this 
formulation may result from the ability of the ethanol solution to improve the 
permeation of NLS in the lipid bilayer matrix of the stratum corneum, thereby 
improving the ability of NLS to disrupt the lipid order. 
      The second part of this thesis showed that a formulation containing a pore-
forming peptide, magainin, and NLS in 50% ethanol synergistically increased skin 
permeability. Increased skin permeability was strongly correlated with decreased lipid 
transition temperatures by DSC and increased wavenumber of CH stretching by FTIR. 
In addition, reduction of lipid component was confirmed by wide and small-angled X-
ray diffraction methods.  Analysis by multi-photon microscopy demonstrated that 
NLS-ethanol increased magainin penetration into the stratum corneum, which further 
increased stratum corneum lipid disruption and skin permeability.  
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      The optimization study lead us to conclude that increased magainin 
pretreatment time increased transport of fluorescein owing to the increasing 
penentration of magainin into the skin. We found the optimum magainin peptide 
concentration to be 1 mM with inhibition occurring above this concentration. This 
concentration dependence was confirmed by FTIR study which investigated lipid 
peak change: lipid fluidization was maximized at 1mM magainin peptide. Moreover, 
the percutaneous penetration enhancement by magainin-NLS formulation was only 
effective for small molecules such as fluorescein. 
 The modification of magainin peptide sequence did not have a significant 
influence on the transdermal enhancement characterisitics of the peptide. By 
investigating the structure and fluidization ability of each modified magainin peptide, 
we have concluded that alpha helicity and fluidization ability are not distinguishing 
factors for percutaneous enhancement.    
   The final part of this thesis showed that a greater increase in skin permeability 
can be realized by manipulating the charge properties of magainin peptide by 
changing pH.  Skin permeability is increased when magainin and the drug have 
attractive electrostatic interactions and decreased when those interactions are 
repulsive. Addition of salt ions interfered with the electrostatic interaction, which 
resulted in decreased enhancement of transdermal flux.  
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 Overall, this thesis presents not only the first study to use a pore-forming 
peptide as a skin penetration enhancer, but also the novel approach to use one 
percutaneous enhancer to increase the penetration of another percutaneous enhancer 
into the skin. From this thesis, it is suggested that antimicrobial peptides can be used 
as efficient skin permeability enhancers in conjunction with other enhancers. By 
changing the pH of the drug solution, we can also control the drug delivery amount. 
Furthermore, magainin peptide has been certified as a safe agent for human use by the 
FDA, and since the peptide did not penetrate deeply into the epidermis or dermis, this 
material could be a great clinical tool for chemical permeation enhancement. Finally, 
this thesis work may shed light on exploring the mechanism of skin permeability 










CHAPTER 9: RECOMMENDATIONS 
 
     This thesis showed that pore-forming peptides can be used as percutaneous 
drug delivery enhancers with co-application of a chemical enhancer. The mechanism 
behind this phenomenon has not yet been completely elucidated, but important factors 
have been uncovered. Lipid disruption or fluidization by chemical enhancer and the 
molecular ionic interaction between delivered molecules and magainin peptide result 
in synergistic transdermal drug delivery enhancement. However, the transport 
pathway, creation of pores, and changes in the magainin structure inside of stratum 
corneum are not clearly understood. Therefore, these should be further investigated.  
In this thesis, only magainin and magainin derivatives were studied in detail; 
however, more antimicrobial peptides could be applied as percutaneous drug delivery 
enhancers. Also, more chemical enhancer-peptide combinations should be explored 
using a number of screening experiments. For the purpose of elucidating the 
mechanism, we could use molecular modeling between the lipid layer and the 
antimicrobial peptide to validate a proposed mechanism.  
Future studies should also evaluate the effects of skin irritation by various 
formulations; finding an optimum formulation of chemical enhancer, peptide 
enhancer, and solvent that has the minimum level of skin irritation will be an 
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important subject to study. Skin irritation potential could be measured using Epiderm 
(MatTek, Ashland, MA) which consists of cell cultures of normal epidermal 
keratinocytes from humans.  
In this thesis, the effects of combining an antimicrobial peptide with a chemical 
enhancer were tested, but antimicrobial peptides could be combined with physical 
transdermal enhancement methods such as electroporation, sonophoresis, 
iontophoresis, laser, and even microneedles. With the aid of physical methods, 
magainin may be delivered into the stratum corenum, then magainin could disrupt the 
lipid domain of the stratum corenum. Application of physical methods can avoid any 
side effects resulting from interaction between peptide and chemical enhancer. Also 
physical methods would be able to shorten treatment times compared to treatment 
times of chemical enhancers. 
For actual medical application, we need to do an intense in vivo study. After the 
conclusion of in vitro experiments using hairless rat epidermis, we could perform in 
vivo experiments using hairless rats which would be a good model for mimicking 
human skin.  
From an economical point of view, the price of magainin synthesis may make 
this approach infeasible. We should find a cheaper method of obtaining the magainin 
peptide. Removal of the purification step could reduce the price of peptide synthesis. 
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(There are no significant differences in skin permeation between magainin with purity 
above 90% and above 50%, data not shown) 
In our studies, we showed that hydrophilic drugs with molecular weight below 
400 Da demonstrated good penetration in our system; however, we need to test 
hydrophobic drugs, which have a transport pathway different from hydrophilic drugs.  
In order to improve patient compliance, we need to minimize the time and 
number of steps required for the application process. Current technology requires two 
separate processes: pretreatment with a chemical enhancer and delivery of the drug 
for transport. If we use two compartments (enhancer and drug) separated by a 
memebrane, after a built-in preatment time, the membrane could be dissolved so that 
drug would be in contact with the skin.     
Finally, the following are some additional advantages of our drug delivery 
system: Permeation by magainin is changed according to the pH change, so we can 
control the permeation of drugs by pH control. In addition, the magainin peptide has 
natural antimicrobial activity; therefore, microbial infection, which is a main concern 





APPENDIX A.1: TRANSDERMAL DELIVERY 




From chapter 3 Figure 3.2, we observed that skin permeability enhancement 
was strongly dependent on ethanol concentration. And from chapter 4 Figure 4.1, 
there is synergisitic skin permeability enhancement by magainin peptide and NLS.  








Figure A.1.1  Effect of ethanol concentration on the enhancement of skin 
permeability to fluorescein for skin treated without (■) and with (□) magainin 
after 5h. Data points show the average of n≥3 replicates and error bars 
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Figure A.1.2 Effect of acidic pH on the enhancement of skin permeability to 
fluorescein for skin treated without (■) and with (□) magainin after 15h. Data 
points show the average of n≥3 replicates and error bars correspond to the 
standard error of the mean.  
 
permeability enhancement. As shown in Figure A1.1, the combination of ethanol with 
magainin peptide produces a trend similar to the previous ethanol study. The 
enhancement by magainin-NLS formulation at 50% ethanol solution is significantly 
larger than other ethanol concentration samples. 
Because the pH of NLS solution was 3.5, we tested the acidic effect on skin 
permeability enhancement. Instead of using an NLS-ethanol solution, we put pH 3.5 
PBS solution in during pretreatment.  As shown in Figure A1.2, acidic pH alone has 
no effect on skin permeability. Additionally, when we put magainin in acidic solution 
in pretreatment we did not observe any enhancement of skin permeability.  
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Finally, from chapter 4 Figure 4.3, we took the image of the skin using multi-
photon microscopy after delivery of sulforhodamine-labeled magainin with and 
without NLS-ethanol treatment. This study used NLS as an enhancer to increase 
penetration of another chemical enhancer, magainin peptide, into the skin. We also 
applied a physical delivery method in order to deliver magainin peptide into the skin 
instead of using a chemical enhancer. We used iontophoresis in pretreatment to 
deliver magainin into the skin for 15 h; however, the skin penetration enhancement 





































                                
Figure A1.3 Effect of delivery of magainin into the skin by iontophoresis on skin 
permeability to fluorescein (Iont: Iontophoresis) 
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APPENDIX A.2: TRANSDERMAL DELIVERY 




We screened various different antimicrobial peptides as percutaneous enhancers in 
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Figure A.2.1 Transdermal fluorescein skin permeability enhancement ratio of 
skin samples treated with NLS and various peptides: 1. NLS only, 2. Magainin, 3. 
Anti-magainin, 4. TD-1, 5. Maximin H5, 6. Pin2, 7. Oxkil, 8. Androctonin, 9. 
Hexapeptide, 10. Thanatin, 11. LL-37, 12. Polyphemusin1, 13. Misugurin, 14. 
Penetratin, 15. Tachyplesin, 16. Protegrin, 17. P5, 18. Fall-39, 19. Clavanin A, 20. 
Indolicidin, 21. Dermcidin, 22. Lys-Leu Peptide, 23. Melittin. Data represent 






Table A.2.1 Characteristics and sequences of various antimicrobial and cell-
penetrating peptides. 
 
 Peptides Character Sequences 
2 Magainin  [68] Antimicrobial peptide GIGKFLHSAKKFGKAFVGEIMNS 
3 Anti-magainin Charge of magainin modified to negative GIGEFLHSAEEFGEAFVGEIMNS 
4 TD-1  [76] Insulun delivery peptide ACSSSPSKHCG 
5 Maximin H5  [182] Anionic antimicrobial peptide ILGPVLGLVSDTLDDVLGIL-NH2 
6 Pandinin 2  [183] Pore-forming antimicrobial peptide FWGALAKGALKLIPSLFSSFSKKD 
7 Oxyopinin l  [183] Pore-forming antimicrobial peptide 
FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSM
ADENAIRQQNQ 
8 Androctonin  [184] Cysteine-rich antimicrobial peptide RSVCRQIKICRRRGGCYYKCTNRPY 
9 Hexapeptide  [185] Short antimicrobial peptide Ac-RRWWCF-NH2 
10 Thanatin  [186] Antimicrobial without pore-forming GSKKPVPIIYCNRRTGKCQRM 
11 LL-37  [187] Human antibiotic peptide LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES 
12 Polyphemusin1  [188] Antiparallel β–hairpin peptide RRWCFRVCYRGFCYRKCR-CONH2 
13 Misgurin  [189] Pore-forming antimicrobial peptide RQRVEELSKFSKKGAAARRRK 
14 Penetratin  [190] Cell-penetrating peptides RQIKIWFQNRRMKWKK 
15 Tachyplesin  [191] Disulfide bond KWCFRVCYRGICYRRCR-CONH2 
16 Protegrin  [192] β-sheet antimicrobial peptide NH2-RGGRLCYCRRRFCVCVGR-CONH2 
17 P5  [193] Excellent antimicrobial peptide KWKKLLKKPLLKKLLKKL-NH2 
18 Fall-39  [194] Human antibiotic peptide FALLGDFFRKSKEKIGKEFKRIVORIKDFLRNLVPRTS 
19 Clavanin A  [195] α-helical antimicrobial peptide VFQFLGKIIHHVGNFVHGFSHVF-CONH2 
20 Indolicidin  [196] Bovine antibiotic peptide ILPWKWPWWPWRR-NH2 





Peptide  [198] 
High positive charge peptide NH2-KLLLKLLLKLLKLWLKLLKLLLK-COOH 






















Figure A.2.2 Circular dichroism spectra of various antimircrobial or cell-
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Figure A.2.2 Continued 
an attempt to find  alternative antimicrobial peptides that provided enhancement. As 
shown in Figure A2.1, none of antimicrobial peptides demonstrate similar skin 
penetration as magianin peptide. Characteristics and sequences of the various 
antimicrobial and cell-penetrating peptides are shown in Table A2.1. 
In Figure A2.2, the structures of peptides were measured using CD-
spectroscopy. Maximin H5, Pin2, Oxkil, LL-37, Misugurin, P5, Fall-39, Clavanin A, 
Dermcidin, Lys-Leu Peptide, and Melittin show alpha helicity in 50% ethanol. 
However, compared with Figure A 2-1, there are no correlations between alpha-
helicity and skin permeability enhancement.  From chapter 5 Figure 5.2, skin 
permeability was strongly dependent on magainin peptide concentration. As shown in      
Figure A2.3, we tested three other antimicrobial peptides and we found that these 
three peptides also show a concentration-dependent effect on skin permeability for 
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fluorescein. Based on these results, we found the optimum concentration of each 
peptide needed to see an increase in skin permeability.     
We compared the skin permeability enhancement of four different peptides at 
their optimum concentration. As shown in Figure Az2.4, 0.25 mM Pin 2 and 1 mM 
Lys-Leu peptide show significantly higher enhancement than NLS only, but this 
enhancement is lower than 1mM magainin peptide. 
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Figure A.2.3 Concentration effect of (A) Lys-Leu (B) Pin2 (C) Oxki1 peptide on 
the transdermal fluorescein skin permeability enhancement ratio (All sample 
treated with NLS). Data points show the average of n≥3 replicates and error bars 
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Figure A.2.4 Comparison of transdermal fluorescein skin permeability 
enhancement ratio of skin samples treated with NLS and selective peptides with 
optimized concentration. 1. NLS only, 2. 1mM Magainin, 3. 0.25mM Pin 2, 4. 0.5 
mM Oxki1, 5. 1mM Lys-Leu Peptide. Data represent averages of n≥3 samples 
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